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CHAPTER 1: INTRODUCTION
In 1895 a breakthrough in signal analysis occurred with the beginning of the ability to measure the
electrical signal of the heart through the electrocardiogram (ECG) (Hurst, 1998). This historical
achievement revealed that heart rate (HR) is noticeably irregular, which was unlike the common
belief at the time (Shaffer et al., 2014). It is well-established today that a healthy heart is not like
a metronome producing monotonously regular beats (Shaffer et al., 2014). The irregularity of HR
is the result of the dynamic interplay between the sympathetic and parasympathetic divisions of
autonomic nervous system (ANS) (Clifford, 2002; Kamath et al., 2012; Shaffer et al., 2014). The
interaction between both systems is modulated by regulatory systems of the body including the
cardiovascular, respiratory, endocrine, and central nervous systems and chemoreceptors and
baroreceptors (Clifford, 2002; Kamath et al., 2012; McCraty, 2015; Shaffer et al., 2014). The
sinoatrial (SA) node integrates the inputs from the ANS and the modulations from the
aforementioned regulatory systems to adjust HR against the constantly changing internal and
external environment for maintaining homeostasis (Maud & Foster, 2006; Shaffer et al., 2014).
This adjustment causes an oscillatory pattern in the HR or beat-to-beat fluctuations in the time
period between sequential heartbeats, termed heart rate variability (HRV) (Maud & Foster, 2006;
Shaffer et al., 2014). Since it is not viable to detect SA node action potentials, the fiducial point of
heartbeat (i.e., P-wave) on the ECG should ideally be determined for calculating HRV (Clifford et
al., 2006; Peltola, 2012). However, the amplitude of P-waves is too low for computer algorithms
to identify them correctly (Clifford et al., 2006; Peltola, 2012). Therefore, the R-waves are used to
measure HRV due to their distinguishable amplitude. For this reason, HRV can also be called RR variability.
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HRV can be analyzed by time, frequency, and non-linear domain measures calculated
from the ECG R-R intervals. Time domain measures demonstrate the variance between sequential
R-R intervals and are used to quantify the amount of variability during the recording (Maud &
Foster, 2006; McCraty, 2015). The most prominent time domain measures include: 1) standard
deviation of normal R-R intervals (SDNN); 2) root mean square of successive differences in
normal R-R intervals (RMSSD); and 3) percentage of successive normal R-R intervals greater than
50 ms (pNN50%). Time domain measures are easy to calculate but are not useful to quantify the
interplay between sympathetic and parasympathetic divisions (Maud & Foster, 2006; McCraty,
2015).
The frequency domain measures are calculated from the power or variance spectral density
analysis of the R-R interval time series (Maud & Foster, 2006; McCraty, 2015). This analysis
provides information on how the power (i.e., variance of a rhythm) is distributed as a unit of
frequency in the hertz (Hz) (Maud & Foster, 2006; McCraty, 2015). Four frequency bands are
determined in the power spectral analysis of the R-R interval time series, including: 1) high
frequency (HF ms2, 0.15-0.40 Hz); 2) low frequency (LF ms2, 0.04-0.15 Hz); 3) very low
frequency (VLF ms2, 0.0033-0.04 Hz); and 4) ultra-low frequency (ULF, ≤0.0033). The discussion
over the use and representation of LF ms2 is still ongoing, but mostly the claim is that LF ms2 is
generated by both the sympathetic nervous system (SNS) and parasympathetic nervous system
(PNS) as well as blood pressure regulation through baroreceptors or by baroreflex modulation only
(Heathers, 2014; Pagani et al., 2012; Reyes del Paso et al., 2013). However, overwhelming
majority of the researchers agree that HF ms2 reflects parasympathetic or vagal modulation
(Akselrod et al., 1981; Malik, 1996; Heathers, 2014). In addition, HF ms2 is also known as
respiratory band because of the strong linear relationship between vagal control of the heart and
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respiratory variation observed in the time difference between two successive R-waves (i.e.,
respiratory sinus arrythmia) (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). The normalized units
of LF and HF and ratio of LF and HF frequency bands (LF/HF) are also commonly reported
frequency domain measures. Although its representation has been a matter of debate due to the
disagreements regarding LF ms2 the LF/HF ratio is used as a marker of sympathovagal modulation,
the autonomic state resulting from the mutually opposing influences of the sympathetic and
parasympathetic activities (Heathers, 2014; Pagani et al., 1984; Pagani et al., 1986) .
Besides traditional time and frequency domain variables, there are also non-linear
measures that show the unpredictability of the R-R interval time series caused by the interactions
among the complex regulatory systems of HRV (Shaffer et al., 2014; Shaffer & Ginsberg, 2017).
The most common non-linear HRV measures consist of: 1) standard deviation 1 (SD1); 2) standard
deviation 2 (SD2); and 3) the ratio of SD2 and SD1 (SD2/SD1). These measures of HRV are
analyzed using Poincare plot method, providing a graph displaying the correlation between
sequential R-R intervals (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). Even though the nonlinear measures have become increasingly reported the physiological representations of such
measures are still ambiguous (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). Nevertheless,
current literature indicates that SD1 represents the baroreflex sensitivity, diastolic blood pressure,
and HR minimum and maximum; SD2 represents baroreflex sensitivity; and SD2/SD1 represents
autonomic modulation during 5 min of recording (Brennan et al., 2001; Guzik et al., 2007; Shaffer
& Ginsberg, 2017).
Low HRV is associated with reduced ability for an organism to deal with the internal and
external causes of stress and counter diseases or recover in timely fashion (McCraty, 2015). The
clinical significance of HRV was highlighted by Hon & Lee for the first time in 1965. They

3

observed that low HRV was the first sign of fetal stress while the HR had no change during labor
and delivery (Lee & Hon, 1965).
Therefore, HRV has become a popular physiological marker for clinicians and researchers
studying clinical populations 1) to determine the early signs of a pathology, the presence of a
chronic disease, or health condition and its treatment prognosis (Pumprla et al., 2002); and 2) to
evaluate the ability to cope with stress and the effectiveness of an intervention (e.g., exercise,
medical procedure) (Mourot et al., 2004; Mourot & Regnard, 2004). Since then, HRV has been
associated with various diseases, cardiovascular disease risk factors, and psychological disorders.
The current literature indicates that low HRV is associated with diabetic neuropathy (Ewing et al.,
1976), myocardial infarction (Pecyna, 2006), sudden cardiac death (Kudaiberdieva et al., 2007),
congestive heart failure (Frenneaux, 2004), metabolic disorders (Stuckey et al., 2014), chronic
renal failure (Axelrod et al., 1987), fibromyalgia (Kang et al., 2016) , non-cardiac chest pain (Ong
et al., 2013), asthma (Kazuma et al., 1997), anxiety (Cohen & Benjamin, 2006), depression
(Carney et al., 2001) , and of relevance to this study, hypertension (Schroeder et al., 2003;
Terathongkum & Pickler, 2004). In addition, HRV has been a useful measure for coaches in a
variety of sport settings since it provides them with an ability to assess and monitor their athletes’
cardiorespiratory fitness (De Meersman, 1993), training intensity, type, and time (Vesterinen et
al., 2016), training periodization (Kiviniemi et al., 2007), performance (Plews et al., 2013),
overtraining (Mourot et al., 2004), and recovery (Mourot & Regnard, 2004).
1.1.Statement of the Problem
Due to the recent technological advances in signal analysis researchers tend to choose HR monitors
over the gold standard criterion ECG for measuring HRV because of their ability to record R-R
intervals (i.e., heartbeats) with easily available, simple-to-use, affordable, and wireless features.
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The apparent ease of accessing HRV via HR monitors has dramatically extended its study in
clinical and athletic populations. Indeed, a recent PubMed search (May 22nd, 2019) showed that
the number of publications associated with HRV rose from 39 in 1977, a year of the first Polar
(Polar Electro Oy) HR monitor to 1785 in 2018. Additionally, the number of studies published
during the last 15 years from 2003 to 2018 (n=15,012) was two times higher than those published
during the 25 years from 1977 to 2003 (n=6,876). The substantial increase in the number of
publications during the last 15 years corresponds to the introduction of new HR monitor
technologies such as Polar RS800TM, S810TM,S810iTM, and the latest version of V800TM as well as
HRV software packages such as Kubios HRV (ver 1.1). Given the increasing credibility of HR
monitors to accurately detect the R-R intervals and the convenience of HRV software packages in
analyzing HRV measures the trend in HRV use among researchers seems likely to continue.
However, artifacts (i.e., random distortion of usual R-R intervals) with technical (e.g., missed
beats) or physiological (e.g., non-sinus beats) origins can impair the ability of HR monitors to
detect accurate R-R intervals to such a degree that HRV measures become no longer meaningful
which may potentially diminish the usefulness of HRV. Hence, multiple researchers have stressed
the necessity of distorted R-R intervals with technical or physiological origins to acquire reliable
HRV measures (De Geus et al., 2019; Kumaravel & Santhi, 2010; Mateo & Laguna, 2003; Nabil
& Reguig, 2015; Peltola et al., 2008; Salo et al., 2001).
Several lines of evidence suggested that the manual correction (MC) of artifacts with visual
identification of the R-R intervals combined with the choice of a proper correction method is the
most accurate method for ensuring comparable HRV measures derived from R-R intervals
between ECG and Polar HR monitors (De Geus et al., 2019; Nabil & Reguig, 2015; Peltola, 2012).
Recently, (Giles et al., 2016) updated the MC methods developed by (Gamelin et al., 2006) by

5

adding two more corrections for artifacts that were discovered with the current Polar HR monitor
V800TM among a healthy population. However, the MC is a laborious process and it requires a
certain level of specialty and expertise, which led to the manufacturing of various HRV software
packages offering easy-to-use automatic correction options to edit artifacts.
Kubios is the most popular HRV software that is used to automatically correct artifacts
cited in about 1000 studies (Kubios HRV [ver. 3.2] User’s Guide, 2019). The latest version of the
software (Kubios HRV Premium [ver. 3.2]) released in January 2019 provides two options for
correcting technical and physiological artifacts, the: 1) automatic correction (AC) and 2) thresholdbased correction (TBC) methods. The AC option was not available in the versions before the first
release of commercial Kubios HRV Premium (ver. 3.0) in January 2017. The AC uses a time series
with differences between sequential R-R intervals to identify artifacts, thereby separating the
physiological and technical artifacts from the sinus rhythm (Kubios HRV User’s Guide, 2018).
While missed beats are edited by adding new R-R intervals, extra beats are corrected by
eliminating extra R-R intervals (Kubios HRV [ver. 3.2] User’s Guide, 2019). The TBC makes
comparisons of each R-R interval against a local R-R interval average (Kubios HRV [ver. 3.2]
User’s Guide, 2019). If an R-R interval exceeds or falls behind the local R-R interval average more
than a selected threshold value, the particular R-R interval is plotted as an artifact for correction
(Kubios HRV [ver. 3.2] User’s Guide, 2019). Several threshold values are available with this
correction method, comprising: 1) very low (0.45 sec); 2) low (0.35 sec); 3) medium (0.25 sec);
4) strong (0.15 sec); 5) very strong (0.05 sec); and 6) custom (a customized threshold in sec)
(Kubios HRV [ver. 3.2] User’s Guide, 2019). With the TBC method, it is recommended to select
the lowest threshold possible to avoid overcorrecting the normal R-R intervals (i.e., N-N intervals)
after visually detecting the artifacts as higher thresholds can lead to measurement bias. Both
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correction methods of Kubios HRV Premium (ver 3.2) replace the detected artifacts with
interpolated R-R intervals using a cubic spline interpolation (Kubios HRV [ver. 3.2] User’s Guide,
2019).
The previous versions of Polar including S810TM (Gamelin et al., 2006; Kingsley et al.,
2005), S810iTM (Vanderlei et al., 2008), RS800CXTM (Vasconcellos et al., 2015), RS800GXTM (De
Rezende Barbosa et al., 2016), and the current version V800TM HR monitors (Caminal et al., 2018);
Giles & Draper 2017; Giles et al., 2016) have been validated among healthy individuals, showing
good agreement between the corrected R-R intervals as well as HRV measures of the Polar HR
monitors and simultaneously recorded 2-lead, 3-lead, 5-lead, and 12-lead ECGs. However, it has
been reported that calculation of HRV measures with separate software packages led to
incomparable results between ECG and several HR monitors in clinical and healthy populations
(Sandercock et al., 2004; Wallén et al., 2012; Weippert et al., 2010). The current version Polar
V800TM HR monitor has not been validated in clinical populations, particularly in individuals with
hypertension. Moreover, it has been shown that the TBC of the previous version of Kubios HRV
(ver 2.2) was not able to correct the certain artifacts properly even though it identified most
artifacts correctly, which resulted in large bias between the HRV measures of ECG and Polar
V800TM (Giles & Draper, 2017).
HRV is a useful physiological marker for assessing autonomic function. Although the
mechanisms causing hypertension are not completely clear one of the potential mechanisms
underlying hypertension is a dysregulation/disruption in autonomic function (Schroeder et al.,
2003). Therefore, validating a portable, non-invasive, easy-to-use technology such as Polar
V800TM that can assess autonomic function in patients with hypertension may help clinicians and
researchers better evaluate mechanisms underlying a patient's hypertension and more effectively
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target therapeutic options. Moreover, since the clinical populations may have a greater number of
artifacts than healthy individuals (Kamath & Fallen, 1995; Peltola et al., 2012), the accurate
correction of artifacts for adults with hypertension is even more important to obtain valid HRV
measures. This requires researchers to be able to choose a method of correction with the highest
editing accuracy. Therefore, establishing the accuracy of the recent version of Kubios HRV
Premium (ver 3.2) with its updated TBC and newly added AC methods and recently updated the
MC method to correct artifacts from the Polar V800TM HR monitor can assist researchers studying
HRV in adults with hypertension to select a method of correction that can produce HRV measures
with highest agreeability between the Polar V800TM HR monitor and the gold standard ECG.
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1.2.Specific Aims and Hypotheses
Specific Aim 1: To compare the corrected and uncorrected (UN) R-R intervals obtained from Polar
V800TM HR monitor to R-R intervals obtained from a 12-lead gold standard ECG among
individuals with hypertension.
We hypothesize: The Polar V800TM HR monitor will produce corrected R-R intervals consistent
and UN R-R intervals inconsistent with a 12-lead ECG among adults with hypertension.
Specific Aim 2: To compare the corrected and UN time, frequency, and non-linear domains of
HRV measures derived from corrected and UN R-R intervals obtained from Polar V800TM HR
monitor to time, frequency, and non-linear domains of HRV measures derived from R-R intervals
obtained from 12-lead ECG among adults with hypertension.
We hypothesize: The Polar V800TM HR monitor will produce time, frequency, and non-linear
domains of HRV measures derived from corrected R-R intervals consistent and the HRV measures
derived from UN R-R intervals inconsistent with time, frequency, and non-linear domains of HRV
measures derived from a 12-lead ECG among individuals with hypertension.
Specific Aim 3: To compare the MC and the Kubios HRV Premium (ver.3.2) TBC and AC
methods to accurately and reliably correct the artifacts (i.e., distorted R-R intervals) obtained from
V800TM HR monitor compared to R-R intervals obtained from 12-lead ECG.
We hypothesize: The MC will correct artifacts obtained from V800TM HR monitor with a greater
accuracy and reliability than the Kubios Premium (ver.3.2) TBC and AC methods compared to RR intervals obtained from 12-lead ECG.
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CHAPTER 2: REVIEW OF THE LITERATURE
2.1. Overview of Heart Anatomy and Physiology
2.1.1. Heart Anatomy and Circulation
The heart is divided into four chambers bordered by myocardium (i.e., heart muscle). These
chambers include the upper left and right atria and lower left and right ventricles. The two atria
receive venous blood returning to the heart, whereas the two ventricles pump the blood from the
heart to lungs and arteries. Venous blood with a lower content of oxygen flows into right atrium
and from there directly into the right ventricle where the pulmonary arteries carry the venous blood
to the lungs for replacing oxygen and removing wastes (Kamath et al., 2012; Maud & Foster, 2006;
McCraty, 2015).

Figure 1. Heart Anatomy and Circulation. A: Aorta; B: left pulmonary artery; C: left pulmonary vein; D: inferior
vena cava; E: right pulmonary vein; F: right pulmonary artery; G: superior vena cava. Credit: clipart-library.com
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The oxygen-rich blood is moved into the left atrium through pulmonary veins and from there to
the left ventricle where the aorta transports the blood to the systemic circulation to meet the oxygen
needs of the tissues (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015). Interatrial septum
,interventricular septum, mitral, tricuspid, pulmonic, and aortic valves keep blood from flowing
back into atria and ventricles (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015).
The heart cycle defines the period from the start of one heartbeat to the start of the next. It
comprises ventricular contraction, a period where the left ventricle ejects blood from the heart
(systole) and ventricular relaxation, a period where the left ventricle relaxes and refills with blood
(diastole) (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015). Myocardial (relating to
the heart muscle) contractions are initiated by a series of electrical impulses, the rate of which
determines the HR. The cells that generate the electrical impulses are called pacemakers. two
internal pacemakers initiating the heartbeat are the sinoatrial node (SA), atrioventricular node
(AV), and Purkinje fibers (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015) (Figure 1).
2.1.2. Autonomic Nervous System
The cardiovascular center is located in the medulla oblongata, a long stem-like structure in the
brainstem. It regulates the rate at which the heart beats through nervous and endocrine systems.
The nervous system comprises central nervous system and peripheral nervous system (Kamath et
al., 2012; Maud & Foster, 2006; McCraty, 2015). The main role of peripheral nervous system is
to link the central nervous system to the limbs and organs, i.e., transmitting the signals between
brain, spinal cord and the rest of the body (Kamath et al., 2012; Maud & Foster, 2006; McCraty,
2015). The peripheral nervous system has two divisions: 1) somatic nervous system (voluntary
motor system); and 2) ANS (involuntary motor system). The ANS branches into the SNS
(responsible for fight or flight response) and PNS (responsible for rest and digests response)
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(Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015). The PNS response exerts its influence
< 1 sec and it is short lasting, but after the onset of the SNS activation, there is a waiting period of
around 5 sec ensued by a stable increase in HR for the next 20-30 sec (Shafer et al., 2014).
However, HR regulation cannot be interpreted as a linear sum of two opposite effects as elevated
parasympathetic activity may not always indicate a decreased sympathetic activity, or vice versa
(i.e., increase in PNS can be related to decrease, increase, or no change in SNS) (Heathers, 2014).
The PNS reactivation during HR recovery as the SNS stays elevated after a bout of exercise is an
example of non-linear interactions between SNS and PNS (Heathers, 2014). Therefore, it is not
appropriate to describe the relationship between the SNS and PNS as demonstrated by a seesaw
where one side moves up another side moves down.
2.1.3. Electrical Signal of the Heart
The SA node is located in the upper right area of the right atrium. In a healthy heart, the SA node
initiates each heartbeat, generating the depolarization (contraction) of the myocardium (Kamath et
al., 2012; Shaffer et al., 2014). The intrinsic frequency of SA node is 60-100 beat per minute. If
the SA node is injured and unable to regulate the HR, the AV node, the intrinsic frequency of
which is 40-60 beats per minute (bpm) can replace the injured SA node as pacemaker (Kamath et
al., 2012; Shaffer et al., 2014). In addition, if the pace making ability of AV is compromised then
Purkinje fibers, the intrinsic rate of which is 15-40 bpm can regulate the HR (Kamath et al., 2012;
Shaffer et al., 2014). Of note, however, Purkinje fibers are triggered as the last resort in the case
of failed SA and AV nodes. The electrical stimulus produced by SA node moves through the atria
to the AV node in approximately 0.03 sec and triggers AV node discharge (Kamath et al., 2012;
Shaffer et al., 2014). Depolarization of the left and right atria of myocardium produce P-wave
(atrial systole) of the ECG. The electrical impulse is rapidly propagated through the bundle of His
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and Purkinje fibers descending down both sides of the septum (Kamath et al., 2012; Shaffer et al.,
2014). As the electrical impulse travels through this region it conducts the electrical impulse over
the ventricles approximately 0.2 sec after the occurrence of the P-wave (Kamath et al., 2012;
Shaffer et al., 2014). The Purkinje fibers depolarize ventricular myocytes and result in the QRS
complex ensued by S-T segment formation (Kamath et al., 2012; Shaffer et al., 2014).

Figure 2. Electrical Conduction System of the Heart. Credit: nurseslearning.com

Ventricular systole starts at the beginning of the QRS complex and expands in the direction of the
S-T segment (Kamath et al., 2012; Shaffer et al., 2014). Ventricular repolarization produces the Twave approximately 0.4 sec after the P-wave occurs. Finally, ventricular diastole occurs 0.6 s after
the start of the P-wave (Kamath et al., 2012; Shaffer et al., 2014). (Figure 2).
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A dynamic interplay between the SNS and PNS systems is considered to be a sign of a
healthy organism (Kamath et al., 2012; Shaffer et al., 2014). Variation in the HR is a demonstration
of the net impact of the interaction between SNS and PNS (McCraty, 2015). The rate of SA node
without any nervous and hormonal influence is around 100 to 120 bpm at rest (Kamath et al.,
2012). However, the predominant branch of the ANS at rest, the PNS inhibits some of the electrical
impulses of SA node and thereby resulting in the net resting HR of 60-100 bpm in healthy
individuals (Kamath et al., 2012). This shows that the predominant neural output comes from the
PNS while the SNS is tonically active (i.e., minimum baseline activity) at rest in health individuals
(Kamath et al., 2012).
The PNS (originating from cranial vagal nerve) slows the HR by stimulating intrinsic
cardiac conduction system that extends toward the SA node, AV, node, and atrial myocardium
(Kamath et al., 2012; Shaffer et al., 2014). Elevated efferent stimulation in the nerves of the cardiac
nervous system activates acetylcholine release, binding to muscarinic receptors (M2) located on
the myocardial fibers (Kamath et al., 2012; Shaffer et al., 2014). This leads to a decrease in the
depolarization of the SA and AV nodes, and thereby, slows the HR. The response to vagal
innervation is instantaneous, takes place within a heart cycle, and therefore, impacts one or two
heartbeat following its onset (Kamath et al., 2012; Shaffer et al., 2014). Once vagal innervation
stops, the HR quickly decreases to its baseline level. The HR can also increase if the vagal
innervation is diminished or blocked. Therefore, the difference in the time between sequential
heartbeats are parasympathetically mediated (Kamath et al., 2012; Shaffer et al., 2014). Elevated
efferent sympathetic nerves (originating from the T1-T4 segments of the spinal cord) stimulate the
SA and AV nodes through the cardiac nervous system (Kamath et al., 2012; Shaffer et al., 2014).
Action potentials resulting from sympathetic stimulation cause the release of norepinephrine,
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binding to beta adrenergic receptors (beta 1) found on myocardial fibers (Kamath et al., 2012;
Shaffer et al., 2014). This results in an increase in the depolarization of SA and AV nodes and
thereby elevating HR (Kamath et al., 2012; Shaffer et al., 2014).
2.2. Overview of HRV
A healthy organism consists of a physiological control system that never rests nor operates in a
static manner (Kamath et al., 2012; Shaffer et al., 2014). For instance; a healthy heart beats highly
irregularly producing variation between one beat and the next as opposed to beating like a
metronome with no variations created (Shaffer et al., 2014). Thus, HR is an indicative biomarker
of the interaction between the sympathetic and parasympathetic divisions of the ANS (Kamath et
al., 2012; Shaffer et al., 2014). The interaction between both branches is constantly occurring in
an effort to reach a relatively stable environment interrupted by internal and external challenges
(Kamath et al., 2012; Shaffer et al., 2014). This dynamic interaction between the PNS and SNS
results in fluctuations in the length of the intervals between heartbeats or beat-to-beat changes, this
is termed HRV. Afferent signals occurring from a various physiological processes including blood
pressure oscillations, thermoregulation, respiration, and circadian rhythm also contribute to the
variability in the HR (Kamath et al., 2012; Shaffer et al., 2014). Therefore, HRV can provide a
window into cardiovascular and respiratory control mechanisms and as a means to examine the
interaction between sympathetic and parasympathetic divisions of the ANS (Kamath et al., 2012;
Shaffer et al., 2014).
2.2.1. Clinical Application of HRV
An optimum level of variability created by the regulatory systems of a body including the
autonomic, cardiorespiratory, endocrine, and central nervous systems as well as chemoreceptors
and baroreceptors is essential for a healthy organism (Heathers, 2014) Whereas a high level of
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variability can be a sign of inefficient physiological functioning and energy utilization, low
variability can be an indication of a pathology (Heathers, 2014) .
The clinical significance of the HRV was first reported by (Lee & Hon, 1965) when they
examined fetal HRV during labor and delivery and its association with fetal health. They found
that changes in HRV precedes fetal stress before any changes take place in the HR itself (Lee &
Hon, 1965). Subsequently in 1970, it was shown that HRV predicted autonomic neuropathy in
patients with diabetes prior to the beginning of symptoms (Ewing et al., 1976). Additionally, low
HRV was linked with higher mortality in patients with acute myocardial infarction (Berntson et
al., 2008), and the chance of sudden cardiac death in patients with acute myocardial infarction
(Sessa et al., 2018).
Since then low HRV has been shown to be a valid and independent predictor of diverse
pathological conditions including chronic renal failure (Axelrod et al., 1987), fibromyalgia (Kang
et al., 2016), asthma (Kazuma et al., 1997), gastrointestinal disorders (Polster et al., 2018),
congestive heart failure (Frenneaux, 2004), sudden cardiac death (Sessa et al., 2018), anxiety
(Cohen & Benjamin, 2006), depression (Carney et al., 2001), and hypertension (Schroeder et al.,
2003; Terathongkum & Pickler, 2004).
2.2.1.1. Effects of Hypertension on HRV
Hypertension is the most commonly observed cardiovascular disease risk factor in the United
States (Arnett et al., 2019) as currently 46% of American adults have hypertension (Arnett et al.,
2019), making it a significant health problem in the country (Arnett et al., 2019). Hypertension
can increase the likelihood of developing coronary artery disease, stroke, renal failure, and cardiac
heart failure (Clifford, 2002). However, the underlying etiology for the development of
hypertension are largely unknown. One of the hypotheses regarding the initiation, progression, and
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maintenance of hypertension is alterations in the neural control of the blood pressure (Kamath et
al., 2012). These neural changes generally emerge as excessive sympathetic stimulation and
parasympathetic inhibition (Esler, 2000). To a great extent, the current literature about HRV
indicate that the vagal modulation of the HR is compromised in patients with hypertension
(Clifford, 2002; Esler, 2000; Esler, 2009; Kamath et al., 2012).
HRV can provide important prognostic information in patients with hypertension. A
number of studies investigated the prognostic importance of HRV in predicting the future risk of
developing hypertension (Chakko et al., 1993; Esler, 2000; Kamath et al., 2012; Schroeder et al.,
2003; Terathongkum & Pickler, 2004). The Atherosclerosis Risk in Communities study with a
sample size of 12,000 showed that the HF ms2 and SDNN were negatively correlated with incident
hypertension after a 3-year follow-up period (Liao et al., 1996). In addition, those with the highest
hypertension had lowest HF ms2 and SDNN and highest LF/HF (Liao et al., 1996). Moreover, the
second trial of the same project showed a negative correlation between the SDNN, RMSSD and
the incident hypertension risk in the subjects followed for 9 years (Schroeder et al., 2003). Similar
studies have further shown that patients with compromised ANS are at a high risk of developing
hypertension. This is in line with the neural alterations (accentuated sympathetic and decreased
parasympathetic activities) characterized with the early stages of hypertension (Julius, 1998;
Kamath et al., 2012; Maver & Štrucl, 2004; Singh et al., 1998).
Antihypertensive medications, however, may be confounding factors in HRV analysis in
patients with hypertension. It has been observed that patients with hypertension who use either βblockers (Greenwood et al., 2000; Kamath et al., 2012), angiotensin-converting enzyme inhibitors
(Binkley et al., 1993) or diuretics (Tsuji et al., 1996) had decreased HRV. However, the overall
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impacts of single or particular combinations of antihypertensive medications on HRV in patients
with hypertension are still debatable (Kamath et al., 2012).
2.3. HRV Signal Assessment
The HRV signal is usually measured by ECG recording detected over a certain period of time
(McCraty, 2015; Peltola, 2012; Shaffer et al., 2014). HR monitors are also used for measuring
HRV and many of those, including the most recent version Polar V800TM, have been validated
(Caminal et al., 2018; Giles et al., 2017; Giles et al., 2016). The algorithms of Polar HR monitors
scan the raw data and identifies particular patterns of data such as the R-wave in the ECG signal
(Nabil & Reguig, 2015). As the first R-peak is captured, the algorithm generates the time between
this and the subsequent R-waves, which is called R-R intervals that are used to calculate HRV
measures (Nabil & Reguig, 2015). This process of calculating R-R intervals repeats until the
recording finishes.
The R-wave of QRS complex is utilized mostly as the fiducial point because of its distinct
amplitude (De Geus et al., 2019; McCraty, 2015; Nabil & Reguig, 2015; Peltola et al., 2008;
Shaffer et al., 2014). However, the true marker of the sinus rhythm is considered the P-wave, as
the P-wave is the closest indicator of atrial depolarization than the R-wave on ECG (De Geus et
al., 2019; McCraty, 2015; Nabil & Reguig, 2015; Peltola et al., 2008; Shaffer et al., 2014). In
practice, the P-wave is too small to accurately detect it by the computer algorithms, particularly in
the presence of artifacts though in theory, it would be more appropriate to utilize P-P intervals for
HRV analysis (De Geus et al., 2019; McCraty, 2015; Nabil & Reguig, 2015; Peltola et al., 2008;
Shaffer et al., 2014). However, several lines of evidence have shown that changes in R-R intervals
reflect the SA node rhythms with high accuracy (De Geus et al., 2019; McCraty, 2015; Nabil &
Reguig, 2015; Peltola et al., 2008; Shaffer et al., 2014). Therefore, the accurate R-wave detection
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is of crucial importance in the obtaining of the reliable HRV outcomes. In other words, the
accuracy of the R-wave detection is correlated with the lower number of artifacts in R-R intervals,
and thus, improved HRV analysis.
The general order of obtaining the time series of the R-R interval formation is as follows:
1) the difference between each sequential R-R intervals is calculated; and 2) length of the
sequential R-R intervals are defined, forming the discrete time series of R-R intervals (Peltola,
2012). The time series of the R-R intervals are not sampled at fixed intervals because of the varying
differences in the length of the neighboring R-R intervals (Peltola, 2012). Not equidistantly
sampled R-R intervals are problematic for frequency domain measures as the power spectral
analysis requires equally spaced R-R intervals (Peltola, 2012). Several methods have been
recommended to avoid this issue prior to the power spectral analysis. A detailed description of
each methods can be found elsewhere (Nabil & Reguig, 2015; Peltola, 2012) as it is beyond the
scope of this thesis.
Another important factor for obtaining accurate HRV measures is the sampling rate of the
data acquisition system (e.g., ECG, HR monitor). Higher sampling frequency ensures the better
resolution of the R-R intervals (Peltola, 2012; Shaffer et al., 2014). Lower sampling frequency
may generate inaccurate HRV measures if the overall variability is abnormally low such as in
patients with heart failure (Sessa et al., 2018; Shaffer et al., 2014). The recommended sampling
frequency is at least 500-1000 Hz (Peltola, 2012; Shaffer et al., 2014).
In 1996, the task force of the European Society of Cardiology and the North American
Society of Pacing and Electrophysiology reported three methods for HRV signal assessment: 1)
time domain analysis; 2) frequency domain analysis or power spectral density analysis; and 3)
non-linear analysis (Malik et al., 1996).
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2.3.1. Time Domain Measures
Time domain measures quantify the amount of HRV during the entire recording and are divided
into statistical and geometric measures. Table 1 shows the most commonly reported statistical and
geometric time domain measures as well as brief descriptions.
Table 1. Statistical and geometric time domain measures
Variables
Units
Description
SDNN

ms

Standard deviation of normal R-R intervals

RMSSD

ms

Root mean square of successive differences normal R-R intervals

pNN50

%

Percentage of successive normal R-R intervals greater than 50 ms

HRV
index
TINN

triangular ms

Integral of the density of the R-R interval histogram divided by
its height
Triangular interpolation of R-R intervals

2.3.1.1. Statistical Measures
Calculations of statistical time domain measures are based on beat-to-beat changes, and thus, are
considered sensitive to outliers and artifacts. Statistical time domain measures (Table 1) from
different studies can be compared with one another provided that the recording time is identical,
and the data are obtained under the similar laboratory conditions (Heathers, 2014; Maud & Foster,
2006; Shaffer et al., 2014).
The SDNN reflects all regular or periodic fluctuations that contribute to the HRV, including
the slow oscillations that reflect the intrinsic ability of the heart react to hormonal stimulants
(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). The SDNN is correlated with VLF,
LF, and total power (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). The actual values
of SDNN change depending on the recording length; when the recording is longer, then the SDNN
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values become higher and vice versa (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
Therefore, SDNN measures acquired from different recording lengths should not be compared
with each other (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Further, it is
considered that SDNN is more accurate when analyzed over longer recordings (24 hr) than shorter
recordings (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
The RMSSD measures the high frequency variations of the HR and reflects the
parasympathetic influence on the heart (Heathers, 2014; Maud & Foster, 2006; Shaffer et al.,
2014). The RMSSD is strongly correlated with pNN50%, HF ms2, and SD1 (Heathers, 2014; Maud
& Foster, 2006; Shaffer et al., 2014). While the RMSSD is less influenced by respiration than is
respiratory sinus arrhythmia, the RMSSD is more influenced by the parasympathetic activity than
the SDNN in general (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
The pNN50% is strongly correlated with RMSDD and HF ms2, reflecting the influence of
parasympathetic activity (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). However,
most researchers prefer to report RMSSD over pNN50% in the time domain measures because it
is thought that RMSSD provides better assessment of the respiratory sinus arrhythmia (Heathers,
2014; Maud & Foster, 2006; Shaffer et al., 2014).
2.3.1.2. Geometric Measures
The basis of the geometric measures is a histogram of the frequency distribution. When the
frequency distribution appears tight and high, it means that all R-R intervals remain within a small
range of values, and thus HRV is low (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
However, when the frequency distribution appears wide and low, it means that R-R intervals
remain within a large range of values, and thus HRV is high. Geometric time domain measures
(Table 1) quantify the shape of the histogram of the R-R tachogram, presenting R-R intervals in
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geometric patterns (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). These measures
are considered insensitive to outliers, and thus, are more likely to be free of artifacts and software
errors in obtaining accurate R-R intervals (Heathers, 2014; Maud & Foster, 2006; Shaffer et al.,
2014). In addition, they are recommended to be used only for long-term (usually 24hr) recordings
as the evidence indicates that they may underestimate overall HRV of short-term recordings
(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Table 4 shows the most commonly
reported geometric time domain measures as well as a brief description.
The HRV index is a measure that captures the duration of the R-R intervals that acts as the
x-axis and the number of each R-R interval that acts as the y-axis of the plot (Heathers, 2014;
Maud & Foster, 2006; Shaffer et al., 2014). The HRV index is calculated by taking the integral of
the density of the R-R interval histogram (i.e., total number of R-R intervals) and dividing it by its
height. Since the results depend on the width of the frequency histogram bin, the width of this bin
is recommended to be set to 1/128 or 7.8 ms (Heathers, 2014; Maud & Foster, 2006; Shaffer et al.,
2014).
The TINN is the baseline width of the normal R-R interval histogram in ms that is assessed
through triangular interpolation. The TINN and HRV index are correlated with SDNN since all
three variables reflect the total variance of HRV (Heathers, 2014; Maud & Foster, 2006; Shaffer
et al., 2014).
2.3.2. Frequency Domain Analysis
The power spectral analysis was established in 1981 by Akselrod et al. for the purpose of
decomposing the HRV waveform into its component rhythms, each representing a specific
physiological influence (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). This finding
of breaking down HRV by power spectral analysis dominated HRV research throughout the 1980s
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(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Power spectral analysis can be
measured by fast Fourier transform model (non-parametric) or autoregressive model (parametric)
(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). While the non-parametric fast Fourier
transform model is fast and straightforward, it may cause spectra with many spikes for short HRV
recordings (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Parametric autoregressive
model, on the other hand, is smoother and more appropriate for short HRV recordings although it
is complicated to establish the optimal autoregressive model order (Heathers, 2014; Maud &
Foster, 2006; Shaffer et al., 2014). Regardless of the methods, the calculation of power spectral
analysis assumes an equally spaced time base, unlike an N-N interval base with variation between
beats (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
Unlike time domain measures, power spectral analysis allows to split the waveform,
thereby revealing the contribution of the separate physiological regulatory mechanisms on HRV
that act at specific frequencies (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
Frequency is the number of events occurring repeatedly per unit of time. Its unit of measures is
the Hz where 0.1 Hz indicates that an event repeats once per every 10 seconds (Heathers, 2014;
Maud & Foster, 2006; Shaffer et al., 2014). Table 2 contains the most commonly reported
statistical and geometric time domain measures as well as brief descriptions.
Table 2. Frequency time domain measures
Variables
Units
Range (Hz) Description
2
VLF
ms
< 0.04
Reflects the circadian rhythms, thermoregulation,
and peripheral vasomotor influences
2
LF
ms
0.04-0.15
Reflects sympathetic and parasympathetic nervous
systems as well as baroreceptors
2
HF
ms
0.15-0.40
Reflects parasympathetic influence and fluctuations
caused by respiration
LF/HF
Reflects the sympathovagal balance
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VLF band requires at least 5 min of recording, but 24 hr recording is considered to be
optimal. The reason for the recording requirement for VLF ms2 is that it represents overall activity
of the various slow physiological fluctuations reported in Table 2 and thus, it cannot be accurately
estimated with 5 min or less of recording time (Heathers, 2014; Maud & Foster, 2006; Shaffer et
al., 2014).
LF band represents the physiological influences reported in Table 2. The PNS can produce
oscillations down to 0.05 Hz, whereas the SNS does not oscillate until >0.1 Hz. Slow respiration
can produce HR oscillations that cross over into the LF ms2. Hence, respiration driven vagal
influences can be part of the LF ms2 if respiration frequency is <8 breaths per minute or if a person
sighs or takes a deep breath (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
HF band represents the physiological influences reported in Table 2. Also, the HF band is
called the respiratory band since it correlates with HR rhythms influenced by the respiratory sinus
arrythmia (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).
LF/HF ratio represents the physiological influences reported in Table 2. Although it still a
matter of debate a low and high LF/HF ratio is considered to reflect sympathetic and
parasympathetic dominance, respectively. Changes in LF/HF ratio may be either because of an
increased sympathetic tone or parasympathetic withdrawal (Heathers, 2014; Maud & Foster, 2006;
Shaffer et al., 2014).
2.3.3. Non-linear Analysis
The requirement for the time and frequency domain measures is that R-R intervals should be
stationary. Non-stationary data indicate sudden variations in R-R intervals, mostly seen as
response to exercise, posture change, or pathology such as hypertension (Heathers, 2014; Maud &
Foster, 2006; Shaffer et al., 2014).
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Abrupt changes frequently occur in the ANS activity due to a variety of physiological or
environmental stimuli, indicating the complexity of the heart rhythms (Heathers, 2014; Maud &
Foster, 2006; Shaffer et al., 2014). Non-linear measures are used to calculate the complexity of
heart rhythm by using the Poincare plot, which is a scatter plot where each R-R interval is plotted
against the next R-R interval (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). In this
way, a graphical representation of cardiovascular rhythms is provided, appearing in an elliptical
shape (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Table 3 shows the most
commonly reported non-linear HRV measures and a brief description.

Table 3. Non-linear measures
Variables
Units
SD1

ms

SD2

ms

SD2/SD1

-

Description
Reflects short-term variability and is correlated with RMSSD
and HF ms2
Reflects long-term variability and is correlated with LF ms2
Reflects the unpredictability of R-R interval time series and is
correlated with LF/HF ratio.

2.4. Artifacts in R-R Intervals
Ideally, R-R intervals should consist of sinus rhythms (i.e., normal R-R intervals) to acquire
accurate and reliable time, frequency, and non-linear HRV measures. However, the R-R intervals
obtained from HR monitors are rarely perfect. Indeed, Polar HR monitors including the S810TM
series, RS800G3TM, and the RS800CXTM, and the recent version of Polar V800TM showed varying
percent of artifact/error rates: Polar S810iTM (6.93%) in healthy adults (Vanderlei et al., 2008),
S810TM (0.40%) in active healthy adults (Gamelin et al., 2006), S810TM (0.32%) (Kingsley et al.,
2005) in healthy adults, and the recent version of Polar V800 (0.08%) (Giles et al., 2016) and
(0.10%) (Giles et al., 2017) in supine position; and the Polar V800TM (0.08% and 0.06%) in healthy
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adults in standing position (Giles et al., 2016; Giles et al., 2017). The presence of artifacts can
considerably distort the HRV signal, and thus, result in erroneous generation of the HRV signal.
Distorted R-R intervals can easily be distinguished as their length is many times larger or smaller
than the sinus rhythm intervals (Nabil & Reguig, 2015). Artifacts in R-R intervals are classified
by technical and physiological origins.
Artifacts with technical origin can result from a variety of reasons. For example; muscle
contractions nearby the heart, especially from chest and arm muscles can distort the R-R intervals
because of the electrical activity created during patient motion (Nabil & Reguig, 2015).
Additionally, loose contact between the skin and chest strap or electrodes or sweating during the
recording can cause artifacts with technical origin (Nabil & Reguig, 2015). Moreover, detection
algorithms may fail to correctly identify the R-waves, causing sudden variations in the HRV (Nabil
& Reguig, 2015). Presence of wireless networks that can interfere the Bluetooth transmission of
HR monitors during the recording can also produce artifacts with technical origin (Giles et al.,
2017).
Artifacts with physiological origins appear when the usual electrical activity of the heart is
impaired due to various reasons. Normal heart rhythms are the result of regular electrical impulses
originating from SA node (Peltola et al., 2012). When the origin of electrical impulses derives
from the outside of the SA node, irregular and abnormal beats are produced such as ectopic
(premature) and atrial or ventricular fibrillation (Peltola et al., 2012). These beats originate from
atria or ventricles rather than SA node. When the origin of abnormal beats is from atria it is termed
pre-mature atrial contraction, while it is termed pre-mature ventricular contraction when the origin
of the beat is the ventricles (Peltola et al., 2012). Ectopic beats introduce signal ambiguity as they
cause preceding and successive R-R intervals to differ from each other (Nabil & Reguig, 2015).
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The appearance of ectopic beats in the time series of R-R intervals is usually viewed as a short RR interval followed by a long R-R interval compared to sinus rhythm intervals or vice versa (Figure
5 and 6) (Nabil & Reguig, 2015). Therefore, the presence of ectopic beats can introduce extensive
source of error into HRV measures (Nabil & Reguig, 2015). Although vast majority of persons
experience ectopic beats, patients with cardiovascular diseases (e.g., myocardial infarction) tend
to have more frequent (90-95%) artifacts with physiological origin as this population is more
vulnerable to premature ventricular and atrial contractions (Kamath and Fallen, 1995; Peltola et
al., 2012). However, technical artifacts are commonly observed with HR monitors regardless of
the type of population.
Artifacts with physiological origins and technical origins can appear simultaneously in the
time series of R-R intervals. Therefore, it is difficult to distinguish artifacts with physiological
origins from artifacts with technical origins (Giles et al., 2017); ectopic beats can look identical to
the following artifact types, particularly as a T1, T2, T3, or T4, which are defined under 2.4.1
Types of Artifacts in R-R intervals (Nabil & Reguig,2015; Giles et al., 2017).
2.4.1. Types of Artifacts in R-R Intervals
Initially, five types of artifact descriptions were developed by (Gamelin et al., 2006) that included
T1 through T5. Later, two more artifact descriptions were added by (Giles et al., 2016) after using
Polar V800TM HR monitor in healthy individuals that include T6a and T6b. The descriptions of all
seven artifacts from T1 to T6b are present below (Giles et al., 2016):
Single Interval of Discrepancy (T1): T1 is defined as a positive or negative single interval
difference > 20 ms (Figure 3). Artifact T1 is undetectable without simultaneous ECG recording
because these may be the result of changes in interval length (Figure 3). An example of the
appearance of T1 in an R-R interval time series would be as follows:
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Figure 3. Appearance of a T1 artifact on the R-R interval tachogram
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Long interval and short interval (T2): T2 is defined as a long interval followed by a short interval
while the two R-R intervals on either side were < 20 ms (Figure 4). An example of the appearance
of T2 in R-R interval time series would be as follows:
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Figure 4. Appearance of a T2 artifact on the R-R interval tachogram

Interval Length (ms)

1.6
1.4
1.2
1
0.8
0.6
0.4
0.2
0
0

1

2

3

4

5

6

7

8

9

Number R-R Interval

Short interval and long interval (T3): T3 is defined as a short interval followed by a long interval
while the two R-R intervals on either side < 20 ms (Figure 5). An example of the appearance of
T3 in R-R interval time series would be as follows:
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Figure 5. Appearance of a T3 artifact on the R-R interval tachogram
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Too few intervals detected (T4): This is considered T4 and defined as missed beats equivalent to
two or three ECG R-R intervals (Figure 6). An example of the appearance of T4 in R-R interval
time series would be as follows:
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Figure 6. Appearance of a T4 artifact on the R-R interval tachogram
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Too many intervals detected (T5): T5 is defined as extra short beat equivalent to one ECG R-R
interval (Figure 7). An example of the appearance of T5 in R-R interval time series would be as
follows:
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.
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Figure 7. Appearance of a T5 artifact on the R-R interval tachogram
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
0

1

2

3

4

5

6

7

8

9

Number R-R Interval

Entirely missed beats (undetectable) (T6a): T6a is defined as entirely missed beats while there is
no difference in the HR monitor time stamp. Artifact T6a is undetectable without simultaneously
measured ECG recording (Figure 8). An example of the appearance of T6a in R-R interval time
series would be as follows:
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134.041
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0. 643

0. 643
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Figure 8. Appearance of a T6a artifact on the R-R interval tachogram
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Entirely missed beats (detectable) (T6b): T6b is defined as entirely missed beat while there is no
difference in the HR monitor time stamp. Artifact T6b is detectable without a simultaneously
measured ECG recording because a larger than expected gap in the time stamp is present (Figure
9). An example of the appearance of T6b in R-R interval time series would be as follows:
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Figure 9. Appearance of a T6b artifact on the R-R interval tachogram
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The current literature shows that the most common artifact type that was detected by the
Polar S810iTM, S810TM, RS800CXTM, and V800TM was T4 (missed beats) with the ratio varying
around 60-90% of the total number of errors in the supine and standing positions (De Rezende et
al., 2016; Gamelin et al., 2006; Giles et al., 2017; Giles et al., 2016; Kingsley et al., 2005; Vanderlei
et al., 2008; Vasconcellos et al., 2015). Even a single artifact can dramatically change HRV
measures, particularly frequency domain variables; a T4 artifact or and ectopic beat has been
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shown to increase HF ms2 and LF ms2 approximately 3-fold in HRV recordings in supine position
(Berntson & Stowell, 1998; Nabil & Reguig, 2015). In addition, technical and physiological
artifacts have been shown to increase SDNN, RMSSD, and pNN50% by approximately 2-fold
(Bruggemann et al., 1993; Nabil & Reguig, 2015). Therefore, artifacts create a serious problem
for obtaining accurate HRV measures and significantly increase the chance of ANS
misinterpretation in healthy and unhealthy populations. The presence of a higher number of
artifacts in clinical populations than that of healthy individuals makes the adults with hypertension
more vulnerable to ANS misinterpretation. Therefore, correction of artifacts with an appropriate
method is essential to prevent potential misinterpretation of ANS that may result in incorrect
diagnosis of adults with hypertension.
2.4.2. Precautions for R-R Intervals Free of Artifacts
The number of artifacts in R-R intervals can be minimized with a well-controlled laboratory
environment and following standard procedures before, during, and following the HRV recording.
In a well-controlled laboratory environment, the following precautions should be taken (Malik et
al., 1996): 1) HRV measurement should be carried out at the same time of a day because of the
circadian rhythm that naturally causes changes in autonomic balance such as the morning and
evening; 2) avoiding too bright a light or noise; 3) maintaining optimum room temperature; and 4)
preparing the skin (i.e., shaving hair on the chest if necessary) for electrode attachment. Premeasurement precautions include (Malik et al., 1996): 1) avoiding caffeine or smoking at least 48
hr before the experiment; 2) avoiding the HRV measurement immediately after a meal (at least 2
hr required); and 3) at least 5 min pre-measurement resting period for the subjects to adjust
themselves to the new environment. During experiment measurement precautions include (Malik
et al., 1996): 1) maintaining a comfortable measurement position (e.g., supine, sitting, or standing);
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2) avoiding movement, talking, or sleeping; and 3) avoiding intentional controlling of breathing.
Collecting the R-R intervals free of artifacts, however, can still be quite challenging in the case of
uncooperative subjects or long-term HRV measurements (Malik et al., 1996). Regardless of the all
precautions, recording of absolutely clean and artifact-free data is difficult. Thus, it is necessary to
review the recording and carefully correct any artifacts before calculating HRV measures to ensure
accurate and reliable data.
2.5. Correction of R-R intervals with Artifacts
As mentioned previously, artifacts can significantly distort time, frequency, and non-linear HRV
measures, especially frequency domain measures. When artifacts are present, the first option
should be to select artifact-free segments of the R-R interval time series (Peltola, 2012). Clean
segments of the R-R interval time series, however, should include no less than 2.5 min to ensure
the accurate calculation of power distribution within a frequency domain (Peltola, 2012). If the
ratio of distorted R-R intervals is <10% (or N-N intervals ≥ 90%) the artifacts can be replaced by
different correction methods before the calculation of HRV measures (Peltola, 2012). However, if
the ratio of distorted R-R intervals is > 20%, rejection of entire recording may be necessary
(Peltola, 2012).
2.5.1. Manual Correction
Artifact correction can be performed manually or automatically using various HRV software
packages. The general consensus regarding the more accurate method for correcting artifacts is the
MC with visual confirmation of the R-R intervals and the appropriate correction method. The MC
cannot be truly replaced with automatic correction software packages (Peltola, 2012). First,
(Gamelin et al., 2006) developed the guideline of methods of correction for T1 through T5. Later,
(Giles et al., 2016) updated it by adding T6a and T6b after their validation of the Polar V800 TM
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HR monitor among healthy individuals. Previously, Gamelin et al., (2006 and Gamelin et al.,
(2008) corrected all artifacts from T1 to T5. However, (Giles et al., 2016) argued that correction
of T1, a difference of 20 ms at a single interval (<50% increase in length over the adjacent
intervals) could be either the result of an actual artifact or random fluctuation in interval length.
Therefore, the detection of a T1 artifact would be impossible without the simultaneously recorded
ECG. Similarly, Giles et al., (2016) concluded that T6a cannot be visible without simultaneous
ECG recording as there seems to be no change in the HR monitor time stamp or R-R intervals
when visually checked. Therefore, only identifiable artifacts (T2-T5, T6b) are recommended to be
corrected following the guidelines below (Giles et al., 2016):
Long interval and short interval: T2 is corrected by averaging the long and short intervals and the
result is replaced with both intervals (Figure 4a). An example of a T2 correction artifact is as
follows: 1.343 (long interval) + 0.143 (short interval) / 2 = 0.743.
Time

R-R Intervals

Correction

247.513

0. 750

0. 750

248.261

0. 748

0. 748

248.999

0. 738

0. 738

250.342

1. 343 [T2]

0. 743

250.485

0. 143

0. 743

251.226

0. 741

0. 741

251.952

0. 726

0. 726

252.663

0. 711

0. 711

.

.

.

.

.

.
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Figure 4a. Correction of a T2 artifact on the R-R interval tachogram

Interval Length (ms)

1.6
1.4

Corrected R-R
Intervals

1.2
1
0.8
0.6
0.4
0.2
0
0

1

2

3

4

5

6

7

8

9

Number R-R Interval

Short interval and long interval: T3 is corrected by averaging the short and long intervals and the
result is replaced with both intervals (Figure 5a). An example of a T3 correction is as follows:
0.282 (short interval) + 1.056 (long interval) / 2 = 0.669.
Time

R-R Intervals

Correction

131.622

0. 725

0. 725

132.337

0. 715

0. 715

133.053

0. 716

0. 716

133.335

0. 282 [T3]

0. 669

134.391

1. 056

0. 669

135.116

0. 725

0. 725

135.830

0. 714

0. 714

136.573

0. 743
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.
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.

.

.

.
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Figure 5a. Correction of a T3 artifact on the R-R interval tachogram
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Too few intervals detected: T4 is corrected by dividing artificially long R-R interval by the number
of missed beats and the result is replaced with the long interval however many missed beats are
present (Figure 6a). An example of a T5 correction is as follows: 2.296 (artificially long R-R
interval) / 3 (missed beats) = 0.765
Time

R-R Intervals

24.245

0. 739

0.739

25.021

0. 776

0.776

25.795

0. 774

0.744

28.091

2.296 [T4]

0.765

28.865

0. 774

0.765
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0. 778

0.765
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0. 760
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.

.
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.

.
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.

.

.
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Correction

Figure 6a. Correction of a T4 artifact on the R-R interval tachogram
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Too many intervals detected: T5 is corrected by adding two extra short R-R intervals together and
the result is replaced with both intervals (Figure 7a). An example of a T5 correction is as follows:
0.286 (extra short R-R interval) + 0.311 (extra short interval) = 0.597
Time

R-R Intervals

Correction

157.670

0. 665

0. 665

158.356

0. 686

0. 686

159.052

0. 696

0. 696

159.338

0. 286 [T5]

0. 597

159.649
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0. 730

160.379

0. 730

0. 895

161.274

0. 895

0. 939
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.

.

.

.

.

.

.

.

.

.
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Figure 7a. Correction of a T5 artifact on the R-R interval tachogram
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Entirely missed beats (detectable): T6b is corrected by subtracting the known interval from the
difference in the time stamp, and the result is replaced with the entirely missed R-R interval and
the known interval (Figure 9a). An example of a T6b correction is as follows: 1.957 (difference in
the time stamp) – 0.842 (the known interval) = 1.115
Time Difference R-R Intervals Correction
55.840

1. 302
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Figure 9a. Correction of a T6b artifact on the R-R interval tachogram
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2.5.2. Additional Manual Correction Methods
Other manual correction methods are available in the current literature including deletion, degree
zero, degree one, and cubic spline interpolations (Nabil & Reguig, 2015; Peltola, 2012)
Interpolation methods (degree zero, degree one, cubic, cubic spline) can be performed using
programming languages comprising MATLAB, Phyton, SciLab, etc. A brief description of these
methods and their impact on HRV measures are discussed below.
In the deletion method, the distorted R-R intervals are eliminated, and previous normal RR intervals are moved to take place of the deleted R-R intervals (Nabil & Reguig, 2015; Peltola,
2012). However, deletion of R-R intervals shortens the length of R-R interval time series, which
can lead to an unacceptable bias in HRV measures, particularly with LF ms2 and HF ms2 (Nabil &
Reguig, 2015; Peltola, 2012). Unlike the deletion, distorted R-R intervals are replaced with normal
R-R intervals in the interpolation methods (Nabil & Reguig, 2015; Peltola, 2012). In these
methods, therefore, the length of the R-R interval time series remains the same, reducing the
chance of bias in HRV measures (Nabil & Reguig, 2015; Peltola, 2012). In the interpolation of
degree zero method, artifacts are replaced with an average R-R interval that is calculated from
adjacent R-R intervals (Nabil & Reguig, 2015; Peltola, 2012). When used on large sections of
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artifacts, the degree zero causes a flat shape on R-R interval tachogram, an inaccurate trend, and
significant biases in LF ms2 and VLF ms2 as the method calculates the same averaged R-R interval
over a whole segment (Nabil & Reguig, 2015; Peltola, 2012). In the linear interpolation method,
a straight line is placed over the artifacts to acquire new R-R intervals (Nabil & Reguig, 2015;
Peltola, 2012). Similarly, with the degree zero method, when this method is used on large sections
of artifacts, it results in slope-like shapes on the R-R interval tachogram (Nabil & Reguig, 2015;
Peltola, 2012). This causes false trends and biases in LF ms2 and VLF ms2 (Nabil & Reguig, 2015;
Peltola, 2012). The cubic interpolation uses four data points to calculate the polynomial (Nabil &
Reguig, 2015; Peltola, 2012). This method is considered a non-linear analysis, examining the
complexity and irregularity of R-R interval time series (Nabil & Reguig, 2015; Peltola, 2012).
Therefore, the presence of a falsely correlated signal may cause problems in obtaining accurate
HR measures, especially if there is high number of artifacts, while it does not result in flat section
in R-R interval tachogram (Nabil & Reguig, 2015; Peltola, 2012). Finally, in the cubic spline
interpolation, corrected values are calculated using numerous data points by placing a third-degree
polynomial (Nabil & Reguig, 2015; Peltola, 2012). Similarly, as with cubic interpolation, spline
interpolation may cause biases in the R-R interval time series if the number of artifacts is high
(Nabil & Reguig, 2015; Peltola, 2012). Technical details of these correction methods can be found
in (Nabil & Reguig, 2015) study.
Giles et al., (2017) assessed the accuracy of deletion, interpolation methods, and Kubios
(ver 2.2) in healthy individuals during incremental exercise with intensities varying from <40% to
80-100% of VO2max. They found that degree one (linear interpolation) resulted in the smallest bias
and effect size (ES) in majority of HRV measures compared to deletion, interpolation methods,
and Kubios HRV (ver 2.2). However, they reported that biases and ESs at exercise intensities >
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60% of VO2max were large for RMSSD, LF/HF ratio, SD1, and Sample Entropy despite of
correction methods. Nevertheless, a consensus regarding the best manual correction method is still
lacking in the current literature while most studies agree that deletion should not be used for artifact
correction.
2.5.3. Automatic Correction
While the MC is more reliable method than automatic correction of artifacts, manual correction is
tedious and requires a long time of careful R-R interval editing and certain level of expertise. For
this reason, various HRV software packages with automatic correction options were developed to
conveniently edit R-R intervals, which may perform sufficiently in healthy adults with small
number of artifacts (Peltola et al., 2012).
These software packages are not only used for automatically correcting artifacts but also
for calculating HRV measures derived from R-R intervals. Some of the software packages are
device-independent suggesting that they are not bundled with ECGs and HR monitors and that RR intervals are downloaded from both devices and uploaded to the software to calculate the HRV
measures. Thus, correction of artifacts from both devices can either be performed manually
independent of the software or automatically with the software, but the calculation of HRV
measures derived from manually or automatically corrected R-R intervals of ECG and HR monitor
are carried out with the same software. Other software packages are device-dependent indicating
that they come bundled with ECGs (e.g., CardioPerfect WorkStation) and HR monitors (e.g., Polar
ProTrainer 5TM) and that artifacts can only be automatically corrected and HRV measures derived
from automatically corrected R-R intervals of ECG and HR monitor are calculated separately by
each devices’ individual software package.
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The most used HRV software package for editing artifacts is Kubios HRV (The Biomedical
Signals Analysis and Medical Imaging Group, University of Kuopio, Finland) with citations in
about 1000 studies (Kubios HRV [ver. 3.2] User’s Guide, 2019). Kubios started producing
commercial (Premium) as well as free (Standard) software packages since January 2017. The
commercial version began with Kubios HRV 3.0 and it was updated in January 2019 with Kubios
HRV 3.2, which can be reached at the following reference (Kubios HRV [ver. 3.2] User’s Guide,
2019). While the Standard version is primarily designed for non-commercial research and personal
use, the Premium version is produced for researchers. Unlike the Standard, the Premium version
calculates all time, frequency, and non-linear measures in addition to presenting time varying
analysis. The Premium version also supports a broad range of ECG and HR in addition to
photoplethysmogram data, whereas the Standard version supports only the data from HR monitors.
The further details of the differences between Standard and Premium versions of Kubios HRV 3.2
are present in the following reference (Kubios HRV [ver. 3.2] User’s Guide, 2019).
Kubios integrates visualizations of the R-R interval time series (i.e., tachogram) via a
graphical interface and offers two artifact correction options including 1) AC; and 2) TBC. The
AC option is available only in Kubios HRV Premium. The AC contains a robust algorithm for
detecting artifacts with technical and physiological origins, which was validated by comparing it
to Massachusetts Institute of Technology-Beth Israel Hospital arrhythmia database, demonstrating
97% and 99.9% of successes in correctly detecting artifacts and normal beats, respectively (86,
87). The technical details of the AC algorithm for detecting and correction artifacts are presented
in the following reference (Kubios HRV [ver. 3.2] User’s Guide, 2019).
The TBC detects and corrects the artifacts if they are outside of the thresholds including
very low (0.45 sec), low (0.35 sec), medium (0.25 sec), strong (0.15 sec), and very strong (0.05
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sec) compared to a local R-R interval average. The correction threshold can also be customized if
the magnitude of difference does not include these thresholds. Each subjects’ data should be
individually treated when using the TBC due to the high inter-individual variations observed in
HRV data. Thus, using the same threshold for every subject can overcorrect the R-R intervals, and
consequently, introduce considerable bias into HRV measures. In addition, the lowest correction
method should always be a priority when using the TBC method to prevent potential
overcorrections of normal R-R intervals (Kubios HRV [ver. 3.2] User’s Guide, 2019).
Figure 10 shows the R-R intervals with artifacts including: A) T3 at 00.00.05; and B) T4
at 00.00.15 and T5 at 00.00.27. Corrections of these artifacts can be applied using the AC or TBC
methods under the RR Interval Time Series Options of the user interface. Whether or not a
correction method affects normal R-R intervals can be seen by checking the plot on the R-R data
axis, showing the total number and percent of artifacts. Plotted artifacts are replaced with R-R
intervals created by the cubic spline interpolation. In addition to automatic artifact correction,
Kubios offers a manual correction option if ECG data are available. Artifacts can be corrected by
fixing the falsely detected R-waves: all R-waves on the R-R tachogram are marked with a “+” sign
(Figure 11). The falsely plotted signs can be adjusted by right clicking and selecting “Move”. If
moving the signs does not correct the artifact, then it can be removed by right clicking and selecting
“Remove” or a new sign (R-peak) can be added by right clicking and selecting “Add”. The details
of the data pre-processing can be found in the following reference (Kubios HRV [ver. 3.2] User’s
Guide, 2019).
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Figure 10. Visual demonstration of Kubios HRV Premium (ver 3.2) corrections of T3, T4, and T5 artifacts on the R-R tachogram

B) T4 error
detected
A) Corrected
R-R Intervals
B) Corrected
R-R Interval

A) T3 error
detected
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Figure 11. Visual demonstration of a falsely detected R-wave and its manual correction
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detected R-wave on RR tachogram
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2.6. Validation of HRV Monitors
Accuracy of HR monitors including the Polar S810TM (Gamelin et al., 2006; Gamelin et al., 2008;
Kingsley et al., 2005), Polar S810iTM (Vanderlei et al., 2008), RS800G3TM (De Rezende Barbosa et
al., 2016) , RS800CXTM (Vasconcellos et al., 2015), and V800TM (Giles et al., 2016) have been
compared to the gold standard ECG with 12-lead, 5-lead, 3-lead, and 2-lead in the supine and
standing positions as well as during exercise (Caminal et al., 2018; Giles et al., 2017). However,
these studies seem to have produced different results depending on the HR monitor, study setting,
artifact correction methods, software package for HRV analysis, and subject characteristics (e.g.,
age, body mass index [BMI], gender, VO2max). Further, the most obvious difference between the
studies was the number of HRV measures, particularly the absence of reporting non-linear
measures.
Error rate in total number of R-R intervals varied depending on HR monitor model. In the
supine position, it appears that the latest version of Polar HR monitor V800TM produced the lowest
error rate. For example; Giles et al., (2016) and Giles et al., (2017) that validated Polar V800TM
reported error rates of 0.08% and 0.10% among healthy individuals, whereas Kingsley et al., (2005),
Gamelin et al., (2006), and Vanderlei et al., (2008) who examined the validity of Polar S810TM
showed error rates of 0.32%, 0.40%, and 6.93% among healthy individuals (Board et al., 2016).
Also, it has been shown that Polar V800TM produced error rates proportional to the exercise
intensity among healthy individuals, which could be the result of increased chest movement during
exercise. Gamelin et al., (2017) who validated the Polar V800TM among 18 healthy individuals
during exercise performed under four intensities (<40%, 40-60%, 60-80%, 80%-100% of VO2max)
reported error rates of 0.90% at <40% of VO2max, 2.25% at 40-60% of VO2max, 3.29% at 60-80% of
VO2max, and 4.46% at 80-100% of VO2max. In addition, Caminal et al., (2018) that validated Polar
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V800TM among 22 healthy individuals during a running of six mountain routes reported an error
rate of 0.71%, which is expectedly higher than those reported at rest.
Current literature of validations studies show that using an identical correction method for
pre-processing (i.e., detection of R-R intervals and correction of artifacts) and software package for
subsequent HRV analyses improves agreeability and interchangeability of the R-R intervals and
HRV measures between HR monitors and simultaneously recorded ECGs.
Agreeability between the corrected R-R intervals of Polar V800TM, RS800CX™, and
S810™ HR monitors and ECGs were high in the supine position. For example; (Giles et al., 2016)
showed bias (i.e., mean difference between two methods of measurement) of 0.06 and limits of
agreement (LoA [i.e., the mean bias ± 1.96 x SD, the total error between two method of
measurement]) ranges of -4.33 to + 4.45 ms between the corrected R-R intervals of Polar V800™
and the ECG among 20 healthy individuals (Board et al., 2016). Similarly, Vasconcellos et al.,
(2015) demonstrated bias of -10 and LoA ranges of -51.1 to 31.0 ms among 15 adolescents with
obesity; and Montano et al., (2016) reported bias of +10 and LoA ranges of 8.0 to 12.0 ms between
the corrected R-R intervals of Polar RS800CX™ and the ECG among 20 healthy individuals (Board
et al., 2016). Additionally, between the corrected R-R intervals of Polar S810™ and the ECG,
(Kingsley et al., 2005) reported bias of -0.06 and LoA ranges of -3.04 to +3.04 ms among 8 healthy
individuals; Gamelin et al., (2006) showed bias of 0.9 and LoA ranges of -11.0 to +13.0 ms among
healthy and physically active individuals; and Porto et al., (2009) reported bias of -1.85 and LoA
ranges of -6.37 to 2.67 ms among 25 healthy and 8 individuals with obesity (n=2), emotional
exhaustion (n=1), mitral valve prolapse (n=2), bicuspid aortic valve stenosis (n=1), Chagas’ disease
(n=1), and Asthma (n=1) (Board et al., 2016).
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Agreeability of the R-R intervals between Polar V800TM and S810TM HR monitors and
ECGs were also high in the standing position. In the standing position, Giles et al., (2016) reported
bias of 0.59 and LoA ranges of -1.70 to +2.87 ms between the corrected R-R intervals of Polar
V800™ and the ECG among healthy individuals. Moreover, between the corrected R-R intervals
of Polar S810TM and the ECG, (Gamelin et al., 2006) showed bias of -0.70 and LoA ranges of -3.89
to 2.50 ms among healthy and physically active individuals and Porto et al., (2009) reported bias of
1.0 and LoA ranges of -6.0 to 8.5 ms among healthy and clinical populations (Board et al., 2016).
While Giles et al., (2017) did not report bias and LoA information of R-R intervals, Caminal
et al., (2018) showed bias of <1 ms and LoA ranges of -3.55 to +3.57 ms among health individuals
during exercise. (Kingsley et al., 2005) validated the Polar S810TM during exercise performed under
the same exercise intensities as those reported by Giles et al., (2017). They did not report biases for
varying exercise intensities but showed that the agreeability decreased as the exercise intensity
increased with LoA ranges varying from -6.79 to 6.75 ms at <40% to -9.16 to 9.10 ms at 80-100%
of VO2max (Board et al., 2016).
Furthermore, interchangeability between the corrected R-R intervals of Polar V800TM,
RS800CX™, and S810™ HR monitors and ECGs was excellent in the supine position. For
instance, it has been shown that intra-class correlations [(ICCs), defined as poor when ICC<0.50,
moderate when ICC was between >0.50 and <0.75, good when ICC was between >0.75 and <0.90,
and excellent when ICC was >0.90 (Koo & Li, 2016)], were 1.00 for Polar V800TM (Giles & Draper,
2018; Giles et al., 2016), 0.98 (Vasconcellos at al., 2015) and 0.99 (Montano et al., 2016) for
RS800CX™ , and 0.99 (Gamelin et al., 2006) and 1.00 (Kingsley et al., 2005) for S810™ (Board
et al., 2016). Moreover, in the standing position, it has been demonstrated that ICCs were 1.00 for
V800TM (Giles et al., 2017; Giles et al., 2016) and 0.99 for S810TM (Gamelin et al., 2006), indicating
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an excellent interchangeability between the HR monitors and ECGs (Board et al., 2016). While
Caminal et al., (2018) and Giles et al., 2017) did not report ICCs during exercise, Kingsley et al.,
(2005) showed that the interchangeability decreased as the exercise intensity increased with ICCs
ranging from 1.00 at <40% to 0.93 at 80-100% of VO2max.
A good agreeability has been confirmed for all time, frequency, and non-linear measures
with small biases and tight LoA ranges calculated from corrected R-R intervals recorded by Polar
S810TM, RS800CXTM ,RS800G3TM and V800TM in supine position and standing position. However,
RMSSD with a bias of -8.1 and LoA ranges of -10.4 to -5.8 ms, LFms2 with bias of 28.0 and LoA
ranges of 25.6 to 30.5 ms2, and HFms2 with bias of -228.0 and LoA ranges of -230.7 to -225.4 ms
(Montano et al., 2016); RMSSD with bias of 13.8 and LoA ranges of -18 to 45.6 ms, pNN50% with
bias of 5.6 and LoA ranges of -15.0 to +26.2 %, LFnu with bias of -7.5 and LoA ranges of -34.7 to
+19.7, and HFnu with bias of 7.6 and LoA ranges of -19.4 to +34.6 for Polar RS800CXTM
(Vasconcellos at al., 2015); and LFms2 with bias of 36.3 and LoA ranges of -42.3 to +114.9 ms2
and HF ms2 with bias of 27.3 and LoA ranges of -137.5 to 192.1 ms2 for Polar RS800G3TM (De
Rezende Barbosa et al., 2016) showed that the agreeability was poor for these variables between
the Polar RS800CXTM and RS800G3TM HR monitors and ECGs in supine position.
Kingsley et al., (2005) that examined the validity of Polar S810TM during exercise bouts
performed at <40%, 40-60%, 60-80%, and 80-100% of VO2max reported high agreeability for LF
ms2 and HF ms2. However, Giles et al., (2017) that compared various correction methods including
Kubios HRV (ver 2.2), deletion, linear interpolation, cubic interpolation, cubic spline interpolation,
and degree zero during exercise bouts at the same intensities reported by Kingsley et al., (2005)
showed poor agreeability for RMSSD, LF/HF, SD1, and Sample Entropy at exercise intensities >
60% of VO2max. Also, Camelin et al., (2018) that validated Polar V800TM among healthy individuals
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who performed six mountain slopes reported a high agreeability with biases <1 and tight LoA
ranges for all HRV measures.
An excellent interchangeability has been confirmed for time, frequency and non-linear
measures calculated form R-R intervals recorded by Polar V800TM and ECG with ICCs ranging
from 0.98 and 1.00 for all other measures in supine and standing positions (Giles et al., 2016). On
the contrary, Nunan et al., (2008) that examined the validity of Polar S810TM among 33 healthy
individuals showed poor interchangeability for LF ms2 with an ICC of 0.70, HF ms2 with an ICC
of 0.65, LF nu with an ICC of 0.51, HF nu with an ICC of 0.62, and LF/HF with an ICC of 0.76.
Similarly, Vasconcellos et al., (2015) reported that Polar RS800CXTM produced poor
interchangeability for pNN50% with an ICC of 0.47, LF nu with an ICC of 0.31, and HF nu with
an ICC of 0.32. In addition, De Rezende et al., 2016 reported that Polar RS800G3TM resulted in
poor interchangeability for LF nu and HF nu with ICCs of 0.74 for both variables (Board et al.,
2016).
Giles et al., (2017) showed that Polar V800TM produced poor interchangeability for LF ms2
with an ICC of 0.67 and HF ms2 with an ICC of 0.68 during an exercise bout performed at 40-60%
of VO2max; VLF ms2 with an ICC of 0.62, LF ms2 with ICC of 0.66, and LF/HF with an ICC of
0.56 during an exercise bout performed at 60-80% of VO2max; and HF ms2 with an ICC of 0.51
during an exercise bout performed at 80-100% of VO2max. Giles et al., (2017), however, reported
an excellent agreement for all HRV measures during exercise bouts performed <60% of VO2max.
Furthermore, Caminal et al., (2018) reported that Polar V800TM resulted in excellent
interchangeability for all HRV measures.
The use of different correction methods for pre-processing of R-R intervals and software
packages can increase the potential for errors. Calculating the HRV measures derived from
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automatically corrected R-R intervals with separate device-dependent software packages results in
incomparable HRV measures the supine position. For example; Wallen et al., (2012) performed
correction of artifacts of the Polar RS800CXTM HR monitor and ECG and subsequent calculations
of HRV measures with individual Polar Pro Trainer (ver. 5.0) and CardioPerfect software packages
among a clinical population with varying level of emotional exhaustion. Although Wallen et al.,
(2012) confirmed the interchangeability for all HRV measures derived from Polar RS800CXTM in
place of those derived from ECG for men with an ICC of 0.8, they did not confirm the
interchangeability for women over 60 years with an ICC <0.75 on any HRV measures. In addition,
it has been shown that the Polar RS800CXTM produced large biases and LoA ranges for all HRV
measures, suggesting low agreeability between both devices among clinical populations (Wallen et
al., 2012). Due to the low agreeability and interchangeability results between Polar HR monitors
and ECGs, the Polar stopped providing device-dependent software packages since December 2015.
The current evidence indicates that accuracy of the Polar V800TM HR monitor improved
compared to the previous versions of Polar S810TM and RS800CXTM. Also, generally high biases
and LoA ranges and low ICCs of the Polar S810TM and RS800CXTM appear to result mainly from
the use of device-dependent Polar software package for the calculation of HRV measures.
Therefore, using an identical device independent HRV software package can prevent the potential
bias into HRV measures derived from HR monitors in clinical populations such as patients with
hypertension. Overall, HR monitors in sports and exercise settings show that SDNN, RMSSD, and
LF/HF ratio consistently have good to excellent interchangeability with ECGs, but this information
is lacking in clinical populations due to the scarcity of research in these individuals.
In conclusion, researchers and clinicians have become increasingly interested in using HR
monitors due their convenience in measuring HRV, a biological marker that is strongly correlated
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with compromised parasympathetic modulation, a common finding among individuals with
hypertension. HRV measures, however, can be substantially distorted by artifacts with technical
and physiological origins when using HR monitors that can lead to errors in interpreting the current
status of hypertension. Therefore, if possible, the segment of R-R intervals free of artifacts should
be selected as a first option. However, if that is not possible and the error rate of a sample >10%
then artifacts should be corrected with a proper method. The MC is the most accurate and reliable
method in correcting artifacts compared to the software packages offering automatic correction
methods. The Polar Pro-trainer (ver.5), a device-dependent software package produce incomparable
HRV measures among healthy and clinical populations due to the failure of correcting artifacts
properly. Hence, Kubios HRV Premium (ver 3.2), a device-independent software package may be
better in correcting artifact more accurately and thus produce comparable measures among healthy
individuals at rest. Since the AC method was not available with the previous versions of Kubios
HRV, the literature does not provide information as to which method of two can be chosen in
correcting artifacts. Of note, however, if an error rate of a sample is >20% the data may result in
inaccurate and unreliable HRV measures regardless of the correction methods. Additionally,
deletion method should be used for correcting artifacts under any circumstances since it introduces
substantial bias into HRV measures. Finally, improving the algorithms of HR monitors in detecting
R-R intervals and the materials (e.g., the chest strap) may reduce the dependence on the artifact
correction methods, which is what makes ECG the gold standard in measuring HRV.
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CHAPTER 3: METHODS
3.1. Study Overview
All subjects attended one laboratory session between 6:00 and 11:00 am. Prior to the resting HRV
measurement, subjects’ chests were cleaned for the ECG attachment and 12-lead ECG electrodes
were placed on subjects. Later, the chest strap (H7) of Polar V800 TM HR monitor was placed just
below the pectoralis major muscles. Then, resting HRV was measured for 5 min in supine position
following 5 min of resting period in the same position. Subjects were instructed to relax as much
as possible but not sleep, move or talk. The R-R interval time series from ECG was stored in
CASETM (ver 6.6) GE Healthcare system while those from Polar V800TM HR monitor was
automatically stored in Polar Flow web service. Subjects completed an informed consent approved
by the Institutional Review Boards of the University of Connecticut and Hartford Hospital. Subjects
were recruited on rolling basis, beginning October 2016 until study completion in May 2018.
3.2. Study Population
Subjects were recruited from the surrounding community with direct mailings and posting of flyers,
media advertisements, social media, previous studies, and from places of work and college
campuses with the posting of flyers, listservs, class announcements, and newsletters. Adults (n=25)
with elevated (SBP ≥120-<130 mm Hg; DPB < 80 mm Hg) to established hypertension (SBP >130
mm Hg; DBP >80 mm Hg) according to the updated American College of Cardiology/American
Heart Association Guidelines for hypertension were enrolled (Arnett et al., 2019). Subjects who
were being sedentary to regularly physically active (i.e., 150 min a week moderate or 75 min a
week vigorous intensity exercise); were free of cardiovascular, pulmonary, renal, metabolic, or
other chronic diseases and depression; did not smoke for at least 6 months prior to entry; and
consumed less than two alcoholic drinks daily were included. Subjects with a medical history of
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cancer-related lymphedema were excluded due to the risk of infection during HRV measurement.
Moreover, subjects were excluded if they were trying to gain or lose weight because of the
confounding effect of weight gain and loss on HRV (Karason et al., 1999). Furthermore, women
who were pregnant, of planning to become pregnant, or were lactating were excluded (Stein et al.,
1999).
3.3. Procedure
Subjects were informed to consume a light breakfast 2-3 hours before and abstain from drinks
containing alcohol and caffeine at least 48 hr before the testing. BMI (kg.m-2) was measured from
body weight and height collected with a calibrated balance beamscale, and waist circumference
(WC) was measured using a Gullick tape at the narrowest part of the torso (Pescatello, 2013).
Testing BP was measured following the standard American Heart Association procedures with an
automated BPTRU monitor (BPTRU Medical Devices; Coquitlam, Canada). The measurements of
BMI, WC, and BP preceded HRV recording that was performed in a supine position in a quiet, lowlight, and temperature-controlled room.
Subjects’ chests were shaved if necessary. The ECG electrodes were placed in the MasonLikar configuration using the GE Stress System (CASE, Milwaukee, WI) (Papouchado et al., 1987).
The ECG signal was checked to ensure that it was consistent and free of noise. After the signal was
confirmed to be acceptable, the Polar V800TM H7 chest strap was fitted below the pectoralis major
muscles and applied as described by the manufacturer. Subjects were placed in supine position for
10 min, but the last 5 min of which was recorded for the analysis. During the recording, subjects
were asked not to move, sleep or talk, and their breathing frequency was paced at 12 breaths/min–1
using a metronome to control for the respiratory influences on HRV.
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3.4. R-R Interval Recording
The 12-lead ECG and Polar V800TM HR monitor with Polar H7 chest strap were started to
simultaneously record R-R intervals at a sampling frequency of 1000 Hz. Cardiology XML files
obtained from ECG were imported into Kubios HRV Premium (ver 3.2) (The Biomedical Signals
Analysis and Medical Imaging Group, University of Kuopio, Finland) in order to export the R-R
intervals detected automatically by its built-in QRS detection algorithm. Kubios HRV Premium
(ver 3.2) marked each R-wave with “+” sign that can be moved or removed to correct falsely
detected R-waves. The detected R-R intervals were manually inspected on the ECG tachogram to
ensure that there were no false R-wave detections. If an R-wave was falsely determined, it was
replaced by moving “+” signs on the correct R-wave. Then the detected R-R intervals from ECG
were saved in a space delimited ASCII text file. In addition, the R-R intervals recorded by Polar
V800TM HR monitor were exported from the Polar Flow web service (Version 2.3; Polar Electro
Oy, Kempele, Finland) in a space delimited ASCII text file.
3.4. Pre-processing of R-R Intervals
3.4.1. Artifact identification
First, the R-R intervals from ECG and Polar V800TM HR monitor in the space delimited ASCII text
files were imported into the same spreadsheet side-by-side. Next the R-R intervals from both
devices were synchronized by inserting 0 ms ensuring the comparison between the ECG and UN
V800TM HR monitor R-R intervals. The technical artifacts (i.e., missed beasts) from the Polar
V800TM HR monitor recordings or physiological artifacts (i.e., non-sinus beats) were then identified
by comparing the R-R intervals from both devices. An artifact from the V800TM HR monitor was
identified when the differences between ECG and Polar V800TM HR monitor R-R intervals were
greater than 20 ms. Subsequently, the differences between the R-R intervals of ECG and Polar
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V800TM HR monitor (i.e., type of artifacts) were assigned one of seven error types of the error
identification and correction guideline developed by Gamelin et al., (2006) and Gamelin et al,m
(2008) and recently updated by Giles et al., (2016). The updated version of the guideline contains
extra two artifacts including T6-a and T6-b that were found with Polar V800TM HR monitor. The
seven types of error are described under the heading of 2.4.1. Types of Artifacts in R-R Intervals in
Chapter 2 (pg. 35-42). We followed the updated guidelines and reported all seven types of artifacts
from T1 to T6b.
3.4.2. Artifact Correction
The artifacts were manually and automatically corrected after their identification. For the MC, nonsinus beats in both signals (N=3) were replaced by interpolated R-R intervals from adjacent R-R
intervals. Corrections were made only for T2, T3, T4, T5, and T6b since it is not possible to identify
T1 and T6b artifacts without simultaneous ECG recordings. Methods of correction for the errors
are described under the heading of 2.5.1. Manual Correction in Chapter 2 (pg.45-50).
The AC and TBC methods of Kubios HRV Premium (ver 3.2) were used to automatically
correct the artifacts. It should be noted that the AC was not available in Kubios versions before the
first commercial Kubios HRV Premium (ver 3.0) was released in January 2017. For the AC,
“Automatic Correction” under “R-R Interval Series Option” was selected and then “ Apply” button
was selected to correct the artifacts. For the TBC, an appropriate threshold among very low (0.45
sec), low (0.35 sec), medium (0.25 sec), strong (0.15 sec), very strong (0.05 sec), and custom under
“R-R Interval Series Option” was selected and then “Apply” button was selected to correct the
artifacts. When the artifacts were corrected with the TBC, the lowest level of correction was chosen
to prevent potential overcorrection. When artifacts were detected by both methods, they were
automatically replaced through the cubic spline interpolation, a type of error correction. After the
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artifact corrections were made, the R-R interval time series was then considered normal and defined
as N-N intervals (Kubios HRV [ver. 3.2] User’s Guide, 2019).
3.4.2. Calculation of HRV Measures
Following the identification and correction of the artifacts, a corresponding segment of the N-N
intervals with varying recording length in the ASCII text files from ECG and Polar V800TM HR
monitor was selected for the calculation of the HRV measures. Commercial Kubios HRV Premium
(ver 3.2) analyzed the selected segments to obtain the time, frequency, and non-linear domains of
HRV measures.
The time domain measures quantify the amount of variability within the sample and they
included SDNN, RMMSD, and pNN50%. Frequency domain measures show the contribution of
SNS and PNS modulation within the sample they included LF ms2 HF ms2, LFnu, HFnu, and LF/HF
ratio. Power spectral density analysis reveals the content of signal’s power (variance) versus
frequency and can be analyzed by the autoregressive and fast Fourier transform methods (Shafer
2017). A fast Fourier transformation was performed to quantify power spectrum density into the
LF (0.04–0.15 Hz) and HF (0.15–0.40 Hz) frequency bands. In addition, normalized units of the
LF and HF bands and LF/HF ratio were calculated. Non-linear domain measures represent the
unpredictable heartbeat dynamics caused by the complex interactions between a number of
regulatory systems and they included SD1, SD2, and SD2/SD1. The non-linear measures were
analyzed as a Poincaré plot, a type of graph where each N-N interval is plotted against next N-N
interval, making a scatter plot (Shafer et al., 2017). The analysis consisted of placing an ellipse to
the plotted points (Shaffer et al., 2017). The SD of each plotted N-N interval from the y= x axis
(SD1 or ellipse’s width), the SD of each plotted N-N interval from the y = x + average N-N interval
(SD2 or ellipse’s length), and SD2/SD1 ratio were then calculated (Shafer et al., 2017).
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3.5. Statistical Analysis
The magnitude of difference between the R-R intervals and HRV measures from ECG and Polar
V800TM HR monitor were calculated by measuring effect size (ES) as the mean difference over the
standard deviation of the difference (Thomas et al., 2010). The ES was defined as trivial when ES
<0.2, small when ES was between >0.2 and <0.5, moderate when ES between >0.5 and <0.8, and
large when ≥0.8 (Cohen 2013). The ICC with the 95% confidence interval (CI) assessed the
concurrent validity (or interchangeable agreement) of the R-R intervals and HRV measures
(Atkinson & Nevill, 1998). The ICC was defined as poor when ICC<0.50, moderate when ICC was
between >0.50 and <0.75, good when ICC was between >0.75 and <0.90, and excellent when ICC
was >0.90 (Koo and Li, 2016). Bland-Altman plots were created for the ECG R-R intervals versus
Polar V800TM HR monitor for the UN, AC, TBC, and MC R-R intervals. The 95% limits of
agreement (LoA) for lower (-1.96) and upper limit (+1.96) were calculated as follows: 1) lower
limit: mean difference - (SD of difference x 1.96); and 2) upper limit: (SD of difference x 1.96) +
mean difference (Bland and Altman, 1986). Homoscedasticity and heteroscedasticity were
inspected through a histogram and Q-Q plot. In the case that was detected in the heteroscedasticity
in HRV measures, the data were logarithmically transformed before the calculation of LoA ranges.
All statistical analyses were conducted using SPSS (Version 24; Chicago, IL, USA)
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CHAPTER 4: RESULTS
4.1. Subject Characteristics
Participants were 17 men (68%) and 8 women (28%) between 18 and 55 years of age who were
overweight to obese with hypertension (Table 4). Of these, six subjects were taking
antihypertension medication that included diuretics (n=1), angiotensin II receptor antagonists
(n=3), and β-Blockers (n=2).

Table 4. Subjects Characteristics (n=25, mean±SD)
Variable
Age (year)
Height (cm)
Weight (kg)
Body Mass Index (kg.m-2)
Waist Circumference (cm)
Heart Rate (bpm)
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)

Results
44.7±10.1
172.3±11.0
93.7±30.6
29.8±4.3
99.9±12.1
73.6±11.0
132.3±12.2
84.3±10.2

4.2. Agreeability and Interchangeability of R-R Intervals
Table 5 presents the type, number, and percent of detected artifacts from the Polar V800TM HR
monitor among the total number of artifacts in the supine position. There were a total of 71 artifacts
among 8325 total R-R intervals yielding an error rate of 0.85%, which was calculated by dividing
the total number of artifacts by the total number or R-R intervals and multiplying the result by 100.
The length of HRV measurement for eight subjects was less than 5 min due to the loss of connection
between the HR monitor and the strap for unknown reasons. Therefore, the average length of the
HRV measurement was 4.6±0.9 min and the number of R-R intervals was 333.0±70.5.
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Figure 13 contains the Bland-Altman plots of the level of agreement and interchangeability
between the R-R intervals from the ECG and the UN, AC, TBC, and MC R-R intervals from the
Polar V800TM HR monitor. The UN R-R intervals from the Polar V800TM HR monitor were
corrected using the AC and TBC methods of Kubios Premium (ver 3.2) and MC. While the bias
(0.69 ms) and ES (0.004) were small, the UN R-R intervals resulted in the widest range of LoA
(from -215.80 to 214.42 ms) (Figure 12). The AC method using the Kubios HRV Premium (ver
3.2) resulted in corrected R-R intervals with higher bias (3.79 ms), range of LoA (from -130.32 to
137.90 ms), and ES (0.024) (Figure 13) than the bias (1.16 ms), range of LoA (from -92.67 to 94.98
ms), and ES (0.008) of the TBC method (Figure 14). The MC method produced corrected R-R
intervals with the smallest bias (0.37 ms), tightest range of LoA (-41.20 to 41.94 ms), and smallest
effect size (0.002) (Figure 15). Furthermore, an improvement in the ICC of the UN R-R intervals
occurred depending on the method of correction that was used. The ICC of UN R-R intervals went
from 0.79 (95 % CI 0.78-0.80) to 0.91 (95 % CI 0.90-0.91) in the AC R-R intervals, 0.95 (95% CI
0.95-0.95) in the TBC R-R intervals, and 1.00 (95% CI 1.00-1.00) in MC R-R intervals.
Table 5. Types of errors detected in the Polar V800TM HR monitor R-R intervals in supine position
Type of Error
Number of Detected Errors
Percent of Detected Errors*
T1
5
7.0%
T2
1
1.4%
T3
5
7.0%
T4
49
69%
T5
7
9.9%
T6a
2
2.8%
T6b
2
2.8%
*Percent of detected errors is calculated as follows: (the number of a particular error/the total number artifacts) x 100. The
total number of errors= 71.
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Figure 12. Bland-Altman plots for the ECG and the UN Polar V800TM HR monitor R-R intervals
Difference between ECG and Polar V800TM UN R-R Intervals (ms)
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Figure 13. Bland-Altman plots for the ECG and the AC Polar V800TM HR monitor R-R intervals
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ECG: electrocardiogram; HR; heart rate; AC; R-R intervals corrected by automatic correction method of the Kubios
HRV Premium (ver 3.2)
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Figure 14. Bland-Altman plots for the ECG and the TBC Polar V800TM HR monitor R-R intervals
Difference between ECG and TBC Polar V800TM R-R Intervals (ms)
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ECG: electrocardiogram; HR; heart rate; AC; R-R intervals corrected by threshold-based correction method of the
Kubios HRV Premium (ver 3.2)
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Figure 15. Bland-Altman plots for the ECG and the MC Polar V800TM HR monitor R-R intervals
Difference between ECG and MC Polar V800TM R-R Intervals (ms)
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4.3. Agreeability and Interchangeability of HRV Measures
Table 6, 7, 8, and 9 contain the comparisons of the HRV measures calculated from UN, AC, TBC,
and MC Polar V800TM HR monitor R-R intervals versus those calculated from ECG R-R intervals
using the Kubios Premium (ver 3.2) software.
The UN resulted in the largest biases and the widest LoA ranges for all HRV measures
compared to the AC, TBC, and MC methods. The UN had ES ranging from 0.091 to 0.835
indicating the magnitude of difference between the HRV measures calculated from UN Polar
V800TM HR monitor and ECG R-R intervals was trivial to large and had 5 out of 11 HRV measures
between 0.2≤ and <0.5, indicating moderate difference. Additionally, the UN had ICCs ranging
from 0.070 to 0.98 suggesting poor to excellent interchangeable agreement but had 7 out of 11
HRV measures below <0.5, indicating poor interchangeable agreement (Table 6). Between the two
correction methods of Kubios HRV Premium (ver 3.2), the TBC resulted in smaller biases than
the AC for SDNN, RMSSD, pNN50%, LFnu, HFnu, LF/HF ratio, SD1, SD2, and SD2/SD1, but
the AC produced smaller biases than TBC for LFms2 and HFms2. Additionally, when the TBC
was compared to the AC method, the TBC produced tighter LoA ranges and smaller ES (<0.031
versus <0.085) for all HRV measures.
Moreover, the TBC method exhibited ICCs varying from 0.96 to 1.00, while the AC had
ICCs ranging from 0.79 to 0.99, indicating that the interchangeability slightly improved from
good-to-excellent to excellent when the correction was made with the TBC (Table 7 and Table 8).
Whereas the MC produced the smallest biases for SDNN, RMSSD, pNN50%, LF/HF, SD1, SD2,
and SD2/SD compared to the AC and TBC methods, the MC caused larger biases for LFms2 and
HFms2 than the AC and also for LFms2, LFnu, and HFnu than the TBC. Additionally, when the
MC was compared to the AC and TBC methods, the MC resulted in the tightest LoA ranges and
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smallest ES (<0.019) for all HRV measures. Furthermore, the MC had ICC of 1 for all HRV
measures indicating excellent reliability for all HRV measures (Table 9).
The possible impact of gender, medication use (particularly β-Blocker use), VO2max, BMI,
and HRV measurement length was examined, but we found that they did not influence the biases,
LoA ranges, ICCs, or ESs of the comparison of the HRV measures calculated from the UN, AC,
TBC, and MC Polar V800TM and ECG R-R intervals.
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Table 6. Comparison of HRV measures calculated from UN Polar V800TM and ECG R-R intervals (mean ± SD)
HRV Measure
ECG
Polar UN
Bias (LoA)
ICC (95% CI)
(mean±SD)
(mean±SD)
SDNN (ms)
55.5±26.7
90.5±62.2
-34.95 (-143.58 to 73.69)
0.27 (-0.07-0.57)
RMSSD (ms)
38.3±29.4
92.8±96.3
-57.51 (-223.81 to 114.78)
0.21 (-0.11-0.52)
pNN50 (%)
13.6±16.2
15.1±15.9
-1.50 (-6.14 to 3.21)
0.98 (0.95-0.99)
LF (ms2)
1215±1352.1
6924.2±16947.2
-5709.13 (-38536.30 to 27118.05)
0.53 (-0.97-0.57)
2
HF (ms )
740.8±1262.8
4861.0±6863.9
-4120.18 (-17136.40 to 8896.033)
0.07 (-0.21-0.39)
LF (nu)
67.3±18.7
59.7±20.3
7.53 (-30.13 to 45.20)
0.49 (0.14-0.73)
HF (nu)
32.7±18.6
40.2±20.2
-7.53 (-45.20 to 30.13)
0.49 (0.14-0.73)
LF/HF Ratio
3.6±4.0
3.0±4.2
0.67 (-3.37 to 4.71)
0.87 (0.72-0.94)
SD1 (ms)
27.1±20.8
65.7±68.2
-38.62 (-158.55 to 81.31)
0.21 (-0.11-0.52)
SD2 (ms)
72.7±33.6
106.5±62.1
-33.80 (-137.14 to 69.53)
0.37 (-0.01-0.66)
SD2/SD1 Ratio
3.4±1.4
2.7±1.6
0.66 (-1.45 to 2.76)
0.68 (0.32-0.85)

Effect Size
0.730
0.765
0.091
0.475
0.835
0.387
0.387
0.163
0.765
0.677
0.442

ECG: electrocardiogram; UN: uncorrected R-R intervals; ICC: intra-correlation coefficient; LoA: limits of agreement; SDNN: standard deviation of normal-to-normal
N-N intervals; RMSSD: root mean square of the successive difference of intervals; pNN50%: the percentage of successive normal cardiac inter-beat intervals greater than
50 msec; LF: low frequency; HF: high frequency; SD: standard deviation.

Table 7. Comparison of HRV measures calculated from Kubios Premium (ver 3.2) AC Polar V800TM and ECG R-R intervals (mean ± SD)
HRV Measure
ECG
Polar AC
Bias (LoA)
ICC (95% CI)
Effect Size
(mean±SD)
(mean±SD)
SDNN (ms)
57.1±28.1
55.5±26.7
-1.60 (-23.27 to 20.06)
0.92 (0.83-0.96)
0.058
RMSSD (ms)
38.3±29.4
36.2±25.4
2.13 (-25.57 to 29.84)
0.87 (0.73-0.94)
0.078
pNN50 (%)
13.1±16.1
13.6±16.2
0.51 (-7.28 to 8.29)
0.97 (0.93-0.99)
0.031
2
LF (ms )
1215±1352.1
1214.2±1360.9
0.80 (-369.45 to 371.06)
0.99 (0.98-1.00)
0.001
HF (ms2)
740.8±1262.8
749.1±1239.5
-8.27 (-1115.84 to 1099.293)
0.90 (0.79-0.96)
0.007
LF (nu)
67.3±18.7
66.7±19.6
0.57 (-24.29 to 25.44)
0.79 (0.57-0.90)
0.030
HF (nu)
32.7±18.6
33.3±19.6
-0.57 (-25.44 to 24.29)
0.79 (0.73-0.95)
0.030
LF/HF Ratio
3.6±4.0
3.5±3.9
0.12 (-1.76 to 2.00)
0.97 (0.94-0.99)
0.031
SD1 (ms)
27.1±20.8
25.6±18
1.51 (-18.12 to 21.14)
0.87 (0.73-0.94)
0.078
SD2 (ms)
72.7±33.6
75.6±36.4
-2.97 (-26.11 to 20.17)
0.94 (0.87-0.97)
0.085
SD2/SD1 Ratio
3.4±1.4
3.4±1.3
-0.07 (-1.01 to 0.87)
0.94 (0.86-0.97)
0.055
AC: R-R intervals corrected by automatic correction method of Kubios HRV Premium (ver 3.2)
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Table 8. Comparison of HRV measures calculated from Kubios Premium (ver 3.2) TBC Polar V800TM and ECG R-R intervals (mean ± SD)
HRV Measure
ECG
Polar TBC
Bias (LoA)
ICC (95% CI)
Effect Size
(mean±SD)
(mean±SD)
SDNN (ms)
55.5±26.7
56.1±27.6
-0.55 (-10.59 to 9.49)
0.98 (0.96-0.99)
0.020
RMSSD (ms)
38.3±29.4
37.8±27.5
0.53 (-9.57 to 10.63)
0.98 (0.96-0.99)
0.019
pNN50 (%)
13.6±16.2
13.8±16.2
-0.16 (-1.33 to 1.02)
0.99 (0.98-1.00)
0.010
LF (ms2)
1215±1352.1
1209.2±1352.5
5.86 (-275.86 to 287.59)
1.00 (0.99-1.00)
0.004
2
HF (ms )
740.8±1262.8
703.7±1201.6
37.07 (-460.59 to 534.74)
0.98 (0.95-0.99)
0.030
LF (nu)
67.3±18.7
67.3±18.0
-0.02 (-4.04 to 4.01)
0.99 (0.99-1.00)
0.001
HF (nu)
32.7±18.6
32.7±18.0
0.02 (-4.01 to 4.04)
0.99 (0.99-1.00)
0.001
LF/HF Ratio
3.6±4.0
3.5±3.9
0.12 (-0.79 to 1.02)
0.99 (0.98-1.00)
0.029
SD1 (ms)
27.1±20.8
26.7±19.5
0.38 (-6.78 to 7.53)
0.98 (0.96-0.99)
0.019
SD2 (ms)
72.7±33.6
73.8±35.7
-1.09 (-14.39 to 12.21)
0.98 (0.96-0.99)
0.031
SD2/SD1 Ratio
3.4±1.4
3.3±1.4
0.03 (-0.74 to 0.80)
0.96 (0.91-0.98)
0.021
TBC: R-R intervals corrected by threshold-based correction method of Kubios HRV Premium (ver 3.2)

Table 9. Comparison of HRV measures calculated from MC R-R intervals between the ECG and Polar (mean ± SD)
HRV Measure
ECG
Polar MC
Bias (LoA)
ICC (95% CI)
(mean±SD)
(mean±SD)
SDNN (ms)
55.5±26.7
55.3±26.7
0.21 (-0.70 to 1.12)
1.00 (1.00-1.00)
RMSSD (ms)
38.3±29.4
38.1±29.1
0.18 (-1.82 to 2.18)
1.00 (0.99-1.00)
pNN50 (%)
13.6±16.2
13.7±16.1
-0.11 (-1.52 to 1.30)
1.00 (0.99-1.00)
2
LF (ms )
1215±1352.1
1208.2±1351
6.85 (-65.77 to 79.48)
1.00 (1.00-1.00)
HF (ms2)
740.8±1262.8
730.9±1267.1
9.94 (-44.20 to 64.07)
1.00 (1.00-1.00)
LF (nu)
67.3±18.7
67.6±18.6
-0.35 (-1.68 to 0.98)
1.00 (1.00-1.00)
HF (nu)
32.7±18.6
32.3±18.6
0.35 (-0.98 to 1.68)
1.00 (1.00-1.00)
LF/HF Ratio
3.6±4.0
3.7±4.0
-0.04 (-0.23 to 0.14)
1.00 (1.00-1.00)
SD1 (ms)
27.1±20.8
27.0±20.6
0.13 (-1.29 to 1.54)
1.00 (1.00-1.00)
SD2 (ms)
72.7±33.6
72.5±33.5
0.21 (-0.55 to 0.97)
1.00 (1.00-1.00)
SD2/SD1 Ratio
3.4±1.4
3.4±1.4
0.01 (-0.14 to 0.15)
1.00 (1.00-1.00)
MC: R-R intervals corrected manually
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Effect Size
0.009
0.006
0.007
0.005
0.008
0.019
0.019
0.011
0.006
0.006
0.005

CHAPTER 5: DISCUSSION
In the current study, we compared raw R-R intervals and HRV measures derived from the Polar
V800TM HR monitor to the gold standard 12-lead ECG to determine their level of agreement and
interchangeability among a sample of 17 men and 8 women with hypertension who were
overweight to obese and of very poor to good cardiorespiratory fitness for men and women of their
age. In addition, we sought to determine the level of accuracy of the MC as well as AC and TBC
methods of Kubios HRV Premium (ver 3.2) in correcting artifacts among this sample. The results
demonstrate that Polar V800TM can provide R-R intervals consistent with the ECG and that HRV
measures calculated from both devices are highly comparable in adults with hypertension in supine
position as long as the raw R-R intervals are corrected.
The error rate in the current study (0.85%) was higher than those reported by Giles et al.,
(2016) (0.08%; -0.77%) and Giles et al., (2017) (0.10%; -0.75%) that validated the Polar V800TM
among healthy adults (n=20 [3 F and 17 M]; n=18 [0 F and 18 M]) with normal BMI (18.5-24.9
kg.m-2) in supine position. This suggests that the performance of the Polar V800TM in the detection
of R-R intervals somewhat declined in adults with hypertension compared to healthy adults in
supine position. The data acquisition and analyses methods were the same between our study and
the studies of Giles et al., (2016) and Giles et al., (2017). However, the autonomic modulation of
our subjects were substantially lower than those reported in both studies as evidenced by declined
time domain measures (SDNN: 55.5 versus 61.4 [Giles et al., 2016] and 81.3 ms [Giles et al.,
2017]; RMSSD: 33.8 versus 55.9 and 75.9 ms; pNN50%: 13.6 % versus 29.1% and 38.9%),
frequency domain measures (HF ms2: 740.8 versus 1827.0 [Giles et al., 2016] and 3978.2 ms2
[Giles et al., 2017]; LFnu: 67.3 versus 41.0 and 36.8; HFnu: 32.7 versus 59.0 and 63.1; LF/HF:
3.6 versus 1.0 and 0.8), and non-linear domain measures (SD1: 27.1 versus 45.0 [Giles et al., 2016]
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and 53.7 [Giles et al., 2017; SD2: 72.7 versus 84.0 and 100.9). Dysregulation/dysfunction of the
ANS, a potential underlying mechanism for hypertension results in diminished R-wave amplitude
(Baron et al., 1980), an important factor that can compromise the ability of HR monitors to
accurately detect the R-R intervals that are used to calculate HRV measures. Therefore,
hypertension may indirectly explain the higher error rate (i.e., higher number of distorted R-R
intervals) observed in the current study.
The most common type of error encountered in the Polar V800TM uncorrected R-R intervals
was T4 (Table 2), which is in accordance with the previous studies reporting the percent of T4
error varying between 60% and 90% of total number of errors (Gamelin et al., 2006; Giles et al,.,
2016; Giles et al., 2017). The T4 may be the result of a decrease in R-wave amplitude due to a loss
or decrease in connection between the chest strap and skin (Giles et al., 2016). The second most
commonly reported artifact in the Polar V800TM uncorrected R-R intervals was T5 with (Table 2).
Gamelin et al., (2006) thought that additional contractions during a single systole lead to T5,
causing HR monitors to misidentify the T-waves or/and P-waves as R-waves. Of note, the Polar
V800TM uncorrected T1 and T6a errors can be seen on the corrected Bland–Altman plots (Figure
15) as outliers, a similar finding reported by Giles et al., (2016). Nevertheless, these errors cannot
be easily seen in the R-R interval time series as opposed to T2, T3, T4, T5, and T6b errors.
The MC was the most successful method of correction with the highest decrease in bias
(0.69 to 0. 37 ms for the UN R-R and the MC), LoA ranges (-215.80 to 214.42 ms and -41.20 to
41.94 ms for the UN R-R and the MC), and the highest increase in ICC (0.79 to 1.00 for the UN
R-R and the MC) compared to the AC (bias: 3.79 ms, LoA ranges: -130.32 to 137.90 ms, and ICC:
0.91) and TBC (bias: 1.16 ms, LoA ranges: -92.67 to 94.98 ms, and ICC: 0.95) methods. The bias
of the MC (0.37 ms) in this study, though somewhat larger, was consistent with Giles et al., (2016)
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who reported bias of 0.06 between the Polar V800TM and ECG. However, LoA ranges of the MC
(-41.20 to 41.94 ms) we found were considerably wider than those (-4.33 to +4.45 ms) reported
by Giles et al (2016). Further, while the bias of Polar V800TM R-R intervals corrected by the MC
was slightly lower than that of Polar S810TM R-R intervals corrected by the MC (0.90), the LoA
ranges we found (-41.20 to 41.94 ms) were noticeably higher than those (-11.0 to +13.0 ms)
reported by Gamelin et al., (2006). These results are consistent with the higher error rate in the
total number of R-R intervals of the current study (0.85%) than those of reported by Giles et al
(2016) (0.08%) and Gamelin et al., (2006) (0.40%), indicating that quality of R-R intervals may
impact the precision of the MC method in correcting artifacts.
The MC may take significant amount of time for artifact correction, and therefore, software
packages like Kubios HRV offers automatic correction methods including the TBC and AC, which
has been only available since 2017 with Kubios HRV Premium (ver 3.0). Previously, Giles et al.,
(2017) showed that the TBC of Kubios HRV (ver 2.2) did not properly correct the artifacts even
though the software accurately identified the artifacts. Specifically, TBC of Kubios HRV (ver 2.2)
replaced T4 error containing two missed beats with one interval rather than the required two. The
same issue with T4 correction is still present with Kubios HRV Premium (ver 3.2). We observed
that the AC, which was not available with Kubios HRV (ver 2.2) properly corrected the T4 errors
containing two missed beats, the erroneous beat was replaced with the required two intervals.
However, the AC was not able properly correct T4 errors containing >2 missed beats, the erroneous
beat was replaced with one interval rather than the required >2 intervals. The problems in both AC
and TBC in correcting T4 errors may explain why both methods resulted in larger biases and ESs,
wider LoA ranges, and lower ICCs than those of the MC and ECG in the current study.
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In addition to the issues with T4 error correction, the AC appears to always overcorrect
three intervals at the beginning and the end of a sample regardless of the artifact condition. This
may explain why the TBC performed better in correcting artifacts with smaller bias (1.16 versus
3.79 ms), tighter LoA ranges ( -92.67 to 94.98 versus -130.32 to 137.90 ms), and higher ICC (0.95
versus 0.9) than the AC when both methods were compared. Nevertheless, the TBC of Kubios
HRV Premium (ver 3.2) produced higher bias (1.6 versus 0.1 ms) and wider LoA ranges (-92.67
to 94.98 versus -0.15 to +0.24 ms) among adults with hypertension than the TBC of Kubios HRV
(ver 2.2) among healthy individuals (Giles et al 2017). Since automatic correction methods in
general perform better among healthy individuals with small number of artifacts (Peltola et al.,
2012) higher error rate in the current study may explain the differences in R-R interval results.
Moreover, time, frequency, and non-linear HRV measures calculated from the Polar
V800TM R-R intervals corrected by the MC and those calculated from ECG showed excellent
agreeability and interchangeability with consistent small biases, tight LoA ranges, trivial ES (i.e.,
ES <0.2, (Cohen et al., 2013), and excellent ICCs (i.e., ICC>0.90, Koo and Li, 2016), similar to
levels of agreeability and interchangeability found in previous studies with the Polar V800TM Giles
et al (2016) and Polar S810TM Gamelin et al., (2006). When time domain HRV measures (SDNN,
RMSSD, and pNN50%) derived from the Polar V800TM and ECG were compared, excellent
agreement was found with small biases, tight LoAs, ICCs in all cases 1.00 and trivial ESs. The
biases of the MC SDNN, RMSSD, and pNN50% (i.e., measures calculated from the Polar V800TM
R-R intervals corrected by the MC) were all < 1 ms, consistent with those reported by Giles et al.,
(2016) and Gamelin et al., (2006). The LoA ranges obtained for the MC SDNN (-0.70 to +1.12
ms), MC RMSSD (-1.82 to +2.18 ms), and MC pNN50% (-1.52 to +1.30 ms) were slightly higher
than those reported by Giles et al., (2016) [(SDNN: -0.22 to +0.24 ms), (RMSSD: -0.32 to +0.32
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ms), and (pNN50%: -1.20 to +0.70 %)] and Gamelin et al., (2006) [(SDNN: -0.47 to +0.63),
(RMSSD: -1.17 to +1.58 ms), and (pNN50%:-2.47 to 3.04%)]. The ESs and ICCs of the MC
SDNN, RMSSD, and pNN50% in the current study, Giles et al., (2016), and Gamelin et al., (2006)
were trivial and excellent, respectively.
The frequency domain measures (LFms2, LFnu, HFm2, HFnu, and LF/HF) calculated from
Polar V800TM R-R intervals corrected by the MC displayed good agreement when compared with
the corresponding ECG HRV measures. The biases of the MC LFms2 (6.85 ms2) and HFms2 (9.94
ms2) in the current study were higher than those reported by Giles et al., (2016) [(LFms2: -0.95
ms2) and (HFms2: 0.45 ms2)] and Gamelin et al., (2006) [(LFms2: 0.06 ms2) and (HFms2: 0.39
ms2)]. Nonetheless, the ICCs between the Polar V800TM and ECG were excellent and the ESs were
trivial ES (ES of LFms2 < 0.005; ES of HFms2) for both LFms2 and HFms2. On the other hand,
biases of LFnu, HFnu, and LF/HF ratio were all <0.50, similar findings to those reported by Giles
et al (2016) and Gamelin et al (2006). The LoA ranges obtained for the MC LF ms2 (-65.77 to
+79.48 ms2 ), MC HF ms2 (-44.20 to +64.07 ms2 ), MC LFnu (-1.68 to 0.98), MC HFnu (-0.98 to
+1.68), and LF/HF (-0.23 to +0.14) were wider than those reported by Giles et al (2016) [LFms 2:
-6.25 ms2 +4.36), (HF ms2: -27.95 to 28.84), LFnu: (-0.72 +0.56), HFnu: (-0.57 to +0.72), and
LF/HF (-0.43 to +0.35)] and Gamelin et al., (2006) [LFms2:-5.82 +5.94) ,(HFms2: -8.63 +9.42),
and LF/HF: -0.18 +0.13)]. However, LoA ranges obtained for MC LFnu (-1.68 to 0.98) and MC
HFnu (-0.98 to +1.68) were tighter than those reported by Gamelin et al., (2006) [LFnu:-1.90
+1.96) and (HFnu: -1.96 + 1.90). The ESs and ICCs of the MC LF ms2, HF ms2, LFnu, HFnu, and
LF/HF in the current study, Giles et al., (2016), and Gamelin et al., (2006) were all trivial and
excellent, respectively. However, when the MC was compared to the TBC and AC, the biases of
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LFms2, LFnu, HF ms2, and HFnu were larger in the MC. Nonetheless, the trivial ESs and excellent
ICCs were present between these variables of Polar V800TM and ECG.
The non-linear measures (SD1, SD2, and SD2/SD1) calculated from Polar V800TM R-R
intervals corrected by the MC also displayed excellent agreement when compared with ECG. The
biases of MC SD1 and SD2 were <0.50, similar findings to those reported by Giles et al., (2016)
and Gamelin et al., (2006) who did not report SD2/SD1 ratio. The bias (0.01) and LoA range (0.14 to +0.15) of SD2/SD1 ratio in the current study showed that SD2/SD1 is highly agreeable
with that of ECG. The LoA range for SD1 (-1.29 +1.54) and SD2 (-0.55 +0.97) were slightly
higher than those reported by Giles et al (2016) [(SD1: -0.21 +0.23) and (SD2: -0.20 +0.24)] and
Gamelin et al 2006 [(SD1:-0.85 +1.15) and (SD2: -0.56 +0.60)].
With the exception of LFms2 and HFm2, the biases (<1 ms), ESs (<0.2), and ICCs (>0.96)
of the all HRV measures calculated from the Polar V800TM R-R intervals corrected by the TBC
of Kubios HRV Premium (ver3.2) and those calculated from the Polar V800TM R-R intervals
corrected by the TBC (only option) of Kubios HRV (ver2.2) in Giles et al (2017) were highly
consistent. However, LoA ranges for the TBC SDNN (-10.59 to 9.49 ms), the TBC RMSSD (-9.57
to 10.63 ms), and the pNN50% (-1.33 to 1.02%) were noticeably wider than those reported by
Giles et al (2017) [(SDNN: -0.25 +0.24), RMSSD: (-0.69 +0.51), and pNN50% (-0.64 +0.72)].
Additionally, the LoA ranges for TBC LF ms2 (-275.86 to 287.59), TBC HF ms2 (-460.59 to
534.74), TBC LFnu (-4.04 to 4.01), TBC HFnu (-4.01 to 4.04), and LF/HF (-0.79 to 1.02) were
substantially wider than those reported by Giles et al., (2017) [(LF ms2: -15.34 to 12.2 ms2), HF
ms2: (-36.11 to 29.077 ms2), LFnu: (-0.82 to 0.672), HFnu: (-0.67 to 0.821), and LF/HF: (-0.23 to
0.18)]. Moreover, the LoA ranges obtained for TBC SD1 (-6.78 to 7.53) and TBC SD2 (-14.39 to
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12.21) were also markedly wider than those reported by Giles et al (2017) [(SD1: -0.49 to 0.36
ms) and (SD2: -0.19 to 0.17 ms)].
The biases of AC SDNN (-1.60 ms), AC RMSSD (2.13), AC pNN50% (0.51%), AC LF
nu (0.57), AC HF nu (-0.57), AC LF/HF (0.12), AC SD1 (1.51), AC SD2 (-2.97), and AC SD2/SD1
(-0.07) were larger than those of the TBC with the exception of AC LF ms2 (0.80 ms2) and AC HF
ms2 (-8.27 ms2). In addition, the LoA ranges obtained for AC SDNN (-23.27 to 20.06), AC
RMSSD (-25.57 to 29.84), AC pNN50% (-7.28 to 8.29), AC LF ms2 (-369.45 to 371.06), AC HF
ms2 (-1115.84 to 1099.293), AC LF nu (-24.29 to 25.44), AC HF nu (-25.44 to 24.29), AC LF/HF
(-1.76 to 2.00), AC SD1 (-18.12 to 21.14), AC SD2 (-26.11 to 20.17), and AC SD2/SD1 (-1.01 to
0.87) were substantially wider than those of the TBC method in the current study. Overall, both
methods of Kubios HRV Premium (ver 3.2) had many of HRV measures outside of the LoA
ranges, suggesting that individual HRV measures are not valid while group HRV measures could
be acceptable with small biases, trivial ESs, and moderate to excellent ICCs.
5.1. Conclusion
This is the first reporting that validated the Polar V800TM HR monitor in detecting R-R
intervals and producing agreeable and interchangeable HRV measures in clinical populations,
specifically in adults with hypertension. Of note, however, researchers should edit raw Polar
V800TM R-R intervals with an appropriate correction method to decrease bias and LoA ranges and
thus to obtain valid HRV measures. Hypertension may be responsible for higher error rate, biases
and wider LoA ranges in R-R intervals and HRV measures in the current study compared to those
reported in healthy individuals since compromised autonomic function reduces R-wave amplitude,
making the detection of R-R intervals difficult for Polar V800TM HR monitor. Therefore,
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correction of R-R intervals with artifacts among adults with hypertension is of higher importance
than that of healthy individuals.
We recommend researchers to choose the MC as a first option for correcting Polar V800TM
artifacts because of the tightest LoA ranges, smallest ESs, and excellent ICCs of 1 for all HRV
measures observed with the MC compared to the Kubios HRV Premium (ver 3.2) methods.
Researchers can identify and correct the artifacts following the current guidelines (i.e., the MC)
detailed in chapter 2 without the simultaneously recorded ECG. However, Kubios HRV Premium
(ver 3.2) can be a second option for those who may find the MC complicated and laborious. In that
case, the TBC should be preferred over the AC as the TBC produced smaller biases than the AC
for all HRV measures with the exception of LF ms2 and HFms2 as well as tighter LoAs, and smaller
ESs for all HRV measures. Since both automatic correction methods produced invalid individual
HRV measures as substantial number of values were outside of LoA ranges researchers should
only report group HRV measures when using Kubios HRV Premium (ver 3.2) for artifact
correction. In addition, the previously described issues with the TBC and AC correction methods
should be addressed in the next versions of Kubios HRV software packages in order to improve
the data accuracy of HRV measures derived from Polar V800TM in adults with hypertension.
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